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ABSTRACT 
Eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus, 
characterized by penetration of eosinophils into the esophageal wall.  Once thought to be a 
rare condition, incidents of EoE are becoming more common.  As EoE has risen to 
prominence, significant effort has been undertaken to successfully diagnose and treat the 
disease.  Most studies of EoE have utilized a typical approach of biological assessment.  
Although this approach is successful, it may neglect fundamental biophysics that impact 
the progression and treatment of the disease.  The use of engineering methods to create a 
physics-based assessment of EoE defines a biophysical model to answer fundamental 
questions concerning EoE development, which can be used in the treatment of the disease.  
The methods and techniques are common in traditional engineering applications and are 
used to obtain insight into a physical system through mathematical application.  This work 
examines a purported relationship between eosinophil concentration and esophageal 
morphology.  The pathogenesis of EoE using conservation principles is performed.  
Finally, a model for delivery of hydrophobic drugs from polymeric micelles is presented, 
which vessels can be utilized for delivery of drugs into the epithelium in the esophagus. 
For Emily, Eleanor, and Virginia 
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Eosinophil granulocytes, or eosinophils, are a type of white blood cells characterized 
by coarse granules within their cytoplasm.  Eosinophils are a key element in combating 
multicellular parasites and are also key participants in allergic responses.1  The  
esophagus, unlike other segments of the gastrointestinal tract, is normally lacking 
eosinophils.2  Thus, a discovery of esophageal eosinophilia signifies an uncharacteristic 
condition.  One such cause of eosinophilia is eosinophilic esophagitis (EoE), an 
inflammatory disease affecting the esophagus.  
Once considered a rare condition, studies demonstrate that eosinophilic esophagitis, 
like other immunologic disorders, is becoming more prominent.3-5  The disease has been 
reported in every populated continent except Africa6 and incidents have risen over several 
decades - affecting more than 300,000 patients per year.7  This increased occurrence is 
likely attributed to both increased occurrence and growing recognition of the disease. 
Eosinophilic esophagitis commonly affects children and adults, with a predilection 
for young males.5  Symptoms are characterized by heartburn, failure to thrive, epigastic 
or chest burn, dysphagia (recurrent in adults), and food impaction (recurrent in adults).  
In many cases, emergency intervention is required during incidents of food impaction.6,8  
In addition, the disease affects the epithelial layer and the endoscopically observed 
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morphology of the esophagus, resulting in plaques or exudates, longitudinal segmentation 
(i.e., periodic rings), and furrows (see Figure 1.1) along the esophagus.9-12 
Based on a patient’s medical history for dysphagia, an esophagogastroduodenoscopy 
(EGD) is collected to obtain esophageal biopsies to diagnose EoE.  Biopsies are collected 
at several locations throughout the esophagus to overcome the “spotty manner” of the 
disease.13  The resultant biopsies are examined for eosinophil concentration (see Figure 
1.2).  Biopsy examinations resulting in 15-20 eosinophils per high power field (1 hpf ≈ 
0.22 mm2) satisfies diagnostic recommendations.14,15  However, elevated eosinophil 
concentrations in the esophagus are not specific to a particular disease.  EoE requires the 
elimination of other causes of esophageal eosinophilia, specifically gastroesophageal 
reflux disease (GERD), which may display eosinophilia albeit at much lower eosinophil 
densities.  EoE is typically distinguished from GERD by persistent esophageal 
eosinophilia, despite acid neutralization therapy.6 
Eosinophil granulocytes are categorized by the presence of small particles, or 
granules, in their cytoplasm (see Figure 2.3).  Each eosinophil granule comprises a core 
and matrix.  These granules contain several cationic proteins within the cellular matrix.  
The granule matrix contains eosinophil peroxidase (EPO), eosinophil cationic protein 
(ECP), and eosinophil-derived neurotoxin (EDN), while a crystalloid core contains major 
basic proteins MBP-1 and MBP-2.6,16,17  Each of these proteins are cytotoxic to most 
tissues, making eosinophils effective combatants against biological parasites.17  
Eosinophil infiltration into the esophagus is characterized by the release of granule 
proteins from activated eosinophils to both the epithelial and sub-mucosal layers.18,19  
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Activation is induced by an immune stimulus and once activated, the eosinophils 
experience degranulation, releasing granule proteins into the surrounding tissue.20-22 
The immune stimulus has been shown to be an allergic response, specifically from 
ingested foods.  Modifying a patent’s diet has shown EoE symptoms can be managed and 
even resolved and EoE-associated inflammation allowed to heal.23  Eliminating foods 
containing milk, egg, soy, wheat, nuts, and fish – foods commonly associated with 
allergic responses – have been effective at reducing EoE symptoms.24  Alternatively, or 
in addition to a modified diet, if EoE symptoms do not subside, common drug therapies 
such as corticosteroids and glucocorticoids may reduce EoE-induced inflammation. 
With the growth of diagnostic incidences, a clinical description of EoE is well 
established.6  Yet a biophysical description of EoE from a systems biology perspective 
has not been significantly examined.  Biophysics is the application of the physical 
sciences to a biological system.  EoE research has primarily been concerned with the 
interaction between the various systems of a cell and how these interactions are regulated 
or treated.  The application of a biophysical study is vital for understanding the origins of 
EoE, which in turn provides avenues for treatments and for assessing improved efficacy 
of those proposed treatments.  
The overall objective of this research study is to use engineering techniques to answer 
fundamental questions concerning EoE development and treatment.  The methods and 
techniques are common in traditional engineering applications (e.g., fluid dynamics, heat 
transfer, etc.) and are used to obtain insight into a biophysical system through 
mathematical application.  Chapter 2 of this work examines if a purported relationship 
exists between the concentration of eosinophils and esophageal morphology through the 
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transport of antigens into the epithelium.  Assessment of the pathogenesis of EoE utilizing 
conservation equations is performed in Chapters 3 and 4.  Finally, a model for delivery 
of hydrophobic drugs from polymeric micelles is presented in Chapter 5.  These micelles 
are proven vessels for delivery of hydrophobic drugs for cancer treatment and may be 
used in the delivery of hydrophobic drugs (e.g., a topically active corticosteroid) for the 
treatment of EoE in the esophagus. 
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Figure 1.1 – Endoscopy images of (a) normal esophagus, (b) esophagus with furrows, (c) 
esophagus with rings, and (d) esophagus with plaques or exudate (images courtesy of 
Fox, et al., Gastrointestinal Endoscopy, 2002; 56:260–270.  and Remedios, et al., Drugs 
March 26 2011, 71(5), 527-40). 
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Figure 1.2 – Comparison between a diseased tissue specimen with eosinophil infiltration 
and a normal esophageal tissue specimen.  Pathology slides courtesy of Hedieh Saffari, 
University of Utah, 2013. 
7 
Figure 1.3 – Intact eosinophil prior to degranulation showing the bilobed nucleus with 
granule proteins in the granules and an intact cytoplasm.  Image courtesy of Hedieh 
Saffari, University of Utah, 2013. 
8 
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CHAPTER 2 
MASS TRANSFER OF ANTIGEN FLOWING DOWN AN IDEALIZED 
ESOPHAGUS 
In a study completed by Saffari, et al.,1,2 eosinophil density in esophagectomy images 
appeared to be a function of the curvature of the esophagus.  To assess the physical cause, 
analysis using computational modeling is performed.  Two idealized geometries with 
varying degrees of esophageal undulations are examined.  Solutions to the models are 
calculated using the commercial program ANSYS® Fluent®.  We hypothesize that the 
observations from Saffari, et al. are correct and eosinophil density does vary as a function 
of curvature within the esophagus in accord with Saffari’s observations.  The result of 
this analysis will link a biophysical model of esophageal morphology to physically 
measured results. 
2.1 Introduction 
Within the esophagus, the distribution of eosinophils in eosinophilic esophagitis 
(EoE) has been shown to be patchy.  In a study completed by Saffari, et al.,1,3 eosinophil 
density was mapped around the circumferential location of the esophagus from 
esophagectomy images.  Those results suggest a general trend that eosinophil density 
varies as curvature of the esophagus varies.  A weak relationship can be seen in Figure 
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2.1, where the curvature from one of the esophageal biopsies is plotted next to its 
corresponding eosinophil density count as a function of the perimeter location.  Although 
the relationship may be weak (in part because of difficulty aligning estimates of curvature 
with Saffari’s data), it is believed that luminal flow in the esophagus is a primary driver 
of antigen mass transfer in the esophagus.  It is expected that luminal flow is influenced 
by the shape of the esophagus.  Thus, a study of the conditions controlling mass transfer 
into the epithelium is required to connect the morphological condition of the esophagus 
and physical data. 
2.2 Methods 
To determine if curvature has an impact on mass transfer, a fluid model is used to 
calculate antigen transport into the esophagus.  The concentration of granule proteins in 
the epithelium is expected to be directly proportional to the concentration of antigen in 
the epithelium. 
To perform a curvature analysis on the esophagus, a mode of antigen transport into the 
esophagus needs to be recognized.  One common mode of transport is a continual flow 
of a luminal film along the epithelium of the esophagus as opposed to a swallowed or 
bolus flow through the esophagus.   
The thickness of the luminal film has not been directly measured, thus an estimate is 
made to broadly cover the range of plausible film thicknesses.  It is known the esophagus 
lacks an adherent mucus layer, but is constantly bathed by swallowed saliva and 
secretions from submucosal glands.4,5  Measurements of the gastrointestinal mucus layer 
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suggest a thickness of approximately 70 µm in the corpus of the gastrointestinal system.4  
Any estimate on the lumen film thickness will likely be within this order of magnitude. 
A thin film model is presented in Figure 2.2. This model assumes a constant flow of 
saliva and secretion flow down the esophagus.  Additionally, this film is present in 
quiescent flow (i.e., between boli) and comprised primarily of saliva.  It is assumed the 
esophageal wall acts as a no slip surface and the fluid remains Newtonian at modest flow 
rates and concentrations.  The film thickness is assumed to be small compared to the 
perimeter and length of the esophagus; this assumption simplifies the model such that 
only r-directional velocities are pertinent. 
Applying the simplifications above, the general momentum conservation equation for 






∆ݖ ൅ ߩ݃௭൰, (2.1) 
where, ݒ௥, ݖ, ߤ, ܲ ௭, ߩ, and ݃ ௭ are the velocity change in the radial-direction, location along 
the esophagus, viscosity of the fluid, the pressure along the esophagus, density, and the 
acceleration due to gravity. 
Thus, the only forces acting on the fluid are gravity and a differential pressure from 
the proximal to the distal ends of the esophagus. 
Using the appropriate boundary conditions on the system, eq (2.1) is solved for the 
velocity, 










∆ݖ ൅ ߩ݃௭൰. (2.3) 
Eq (2.3) is the average velocity in the luminal film and is governed primarily by the 
pressure and gravity forces.  To solve for the thickness of the film, it is assumed the 
variation along the curvature is sufficiently small, thus the average velocity is related to 




where ሶܳ , ݌ఏ, and H are the volumetric flow rate, perimeter of the esophagus, and 
thickness of the lumenal film. 
The lumenal film thickness is then determined by combining eqs (2.3) and (2.4) and 
solving for the film thickness,  
ܪ ൌ ቆ ଷொሶఓ௣ഇቀ∆ು೥∆೥ ାఘ௚೥ቁቇ
ଵ ଷൗ
.  (2.5)
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The Bond and Capillary ratio gives the ratio of the body forces to viscous forces in a 








This equation gives the thickness of the film as a function of the Bo/Ca ratio, which 
represents the ratio of body forces to viscous forces acting on the fluid flow in the 
esophagus.  In this formulation, the numeric value of the Bo/Ca ratio is dependent on 
what forces are applied to the system.  The numerical value of the ratio would be large as 
the viscous forces become large and small for large body forces (e.g., large pressure 
differential). 
The thickness of the fluid layer flowing within the esophagus, given in eq (2.8), is 
primarily a function of two possible scenarios.  One potential scenario utilizes 
gravitational force on the liquid without a pressure gradient, for instance when no 
pressures are exerted through swallowing.  The other is the application of gravitational 
force and a differential pressure along the esophagus (e.g., flow under the influence of a 
bolus).  Both scenarios are used to constrain the thickness of the luminal film to a 
maximum and minimum thickness. 
As the film thickness increases, the model becomes a multidimensional system.  
Curvature and length of the esophagus must be accounted for.  An analytical solution is 
not easily obtained to successfully model the fluid flow and mass transport down the 
esophagus unless the film thickness is small.  Since the film thickness is not known 
experimentally, a parametric analysis of the definition given in eq (2.8) is used to define 
a plausible range of luminal fluid thickness for the model.  A customized computer code 
could be written, but the commercial Computational Fluid Dynamics (CFD) program 
ANSYS® Fluent® is selected due to the program’s flexibility and ease of use for the 
purposes and intent of this analysis. 
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The start of all computational methods is the generation of an applicable geometry 
that can tie the model to a physically realistic system.  The cross-sectional geometry in 
Figures 2.3a and 2.3b was prepared as an idealization of an esophageal shape.  These 
shapes were selected based on geometrical simplicity, focusing on curvature differences, 
while simultaneously approximately representing some observed esophagectomy images 
(see Figure 2.3c). 
Recognizing the symmetry present in the idealized geometry in Figures 2.3a and 2.4b, 
only a fraction of the geometry must be modeled.  Figure 2.4 shows the simplification 
applied to the geometry.  Figure 2.5 shows a view of the mesh for one of the models used 
in this assessment along the negative z-axis.  Throughout this analysis, mesh skewness 
was kept below 0.85 to avoid divergence in the solution of the model.  The meshed 
geometry was imported into Fluent® and boundary conditions set to simulate the expected 
mass transfer configuration (see Figure 2.6).  The epithelium was defined as a porous 
media with porosity and permeability.   
In Fluent®, a permeable membrane is defined by the porosity and an associated 
frictional factor.  The flow of material in the permeable membrane (i.e., epithelium) is 
simplified as a fluid flow through a packed bed.  Assuming the fluid film has laminar 
flow with a velocity sufficiently low for Re<10, the Blake-Kozeny or Kozeny-Carman 
equation6 can be used to define the bed friction factor as,  





The friction factor from eq (2.9) is a function of the porosity, ߳, particle diameter, ܦ௣, 
average velocity, ̅ݒ௦, and liquid’s properties.  The porosity of a healthy epithelium has 
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been measured to be approximately 0.43.7  The diameter of epithelial cells are assumed 
spherical, and measured to be around 0.4 µm.8  
The liquid in the film has the same general properties as water, but also contains a 
casein mole fraction of 0.03 to simulate the amount of casein present in milk.9  Casein is 
a family name for related phosphorproteins commonly found in mammalian milk.10  
Casein was chosen due to its history of inciting allergic responses.10  The epithelium 
transport of casein was approximated using Stokes-Einstein diffusion coefficients and 
experimental approximations provided by Bergman, et al.11  There was no species 
diffusive flux along all epithelial boundaries.  The flux was set to zero due to Fluent®’s 
inability to simply specify the mass transfer flux along a boundary without producing 
potentially erroneous results of negative concentrations. 
Three main variables are assessed to determine the effect of the esophagus curvature 
on casein concentration within the epithelium.  The most significant variable is the 
curvature of the idealized esophagus, shown in Figures 2.3a and 2.3b.  Fluid film 
thickness is relatively unknown and is also varied based on an assessment generated from 
eq (2.8).  Finally, the other potential major impact parameter is the porosity of the 
epithelium, which will impact the concentration profile of casein in the epithelium.  A 
summary of values and boundary conditions is given in Table 2.1. 
The dependence of curvature of the esophagus is evaluated by using minimum and 
maximum film thicknesses from eq (2.8) and by varying the degree of curvature in the 
idealized esophagus (shown in Figures 2.3a and 2.3b).  A comparison between the 
concentration of casein in the peaks and valleys of the epithelium in each scenario is 
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performed to characterize the effect of curvature on casein concentration in the 
epithelium. 
2.3 Results and Analysis 
The thickness of the luminal film was determined through a parametric analysis of 
the Bo/Ca ratio defined in eq (2.8).  A volumetric flow between 0.3 and 10 mL/min (from 
salivary rates12,13) was used with and without the effect of a pressure differential.  Using 
this method, the film is thinnest, between 16 and 70 µm, when a pressure gradient of 80 
Torr14 is applied to the esophagus and thickest, between 29 and 123 µm, when the 
pressure gradient is neglected, similar to the 70 µm from literature.4  Figure 2.7 shows 
the applicable range of fluid film thicknesses.  These maximum and minimum values are 
used in the development of the Fluent model.  
Using the simplified geometries of the esophagus and the parameters (see Table 2.2) 
in Section 2.2, the solutions are calculated under steady state conditions.  The steady state 
model is used to produce a conservative result for the concentration profile within the 
epithelium.  Figures 2.8 through 2.11 show the regions of significant change within the 
model for each condition.   
Figure 2.8 shows the mass fraction of casein in an epithelium with small undulations 
down the length of the esophagus for a “thick” fluid layer of 80 µm.  Figure 2.8a shows 
the result for low porosity and Figure 2.8b for high porosity.  Likewise, Figure 2.9 shows 
the mass fraction of casein in an epithelium with small undulations down the length of 
the esophagus for a “thin” fluid layer of 16 µm.  Figure 2.9a shows the result for low 
porosity and Figure 2.9b for high porosity.   The differences in these results are quite 
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pronounced.  The porosity appears to have little impact on the shape and form of the 
concentration profile, as opposed to the fluid film thickness (see Table 2.2).   
Figure 2.10 shows the mass fraction of casein in an epithelium with large undulations 
down the length of the esophagus for the thick fluid layer.  Figure 2.10a shows the result 
for low porosity and Figure 2.10b for high porosity.  Similarly, Figure 2.11 shows the 
mass fraction of casein in an epithelium with small undulations down the length of the 
esophagus for the thin fluid layer.   The differences in these results are also quite 
pronounced and different from the small undulations seen in Figures 2.8 and 2.9.  For all 
conditions, the porosity appears to have little impact on the mass transfer, with the fluid 
film thickness having a large impact on the mass fraction profile. 
Comparing the different curvatures for each of the conditions shows the curvature has 
a significant impact on the shape of the mass fraction profile in the epithelium.  This can 
be seen in Figure 2.12, where a decrease in mass fraction at the extrema of the curvature 
is present.  This dependence is most likely due to forces causing excessive shear flow in 
those regions due to the fluid-surface contact. 
Table 2.2 shows a comparison of integrated concentrations along the center-line of 
the epithelium at each peak and valley of the undulations.  The difference in integrated 
mass fraction between the models with small undulations is no more than 7.4%, while the 
models with large undulations are at least double the low result.  This indicates a strong 
dependence between mass fraction concentration profile and curvature.   
Interestingly, the majority of a mass fraction change is in the proximal region of the 
esophagus.  It is fair to assume the concentration of antigen, like casein, is proportional 
to eosinophil concentration within the epithelium, but this phenomenon is not directly 
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measured during the analyses of esophagectomy slices.15  The result from the model is 
most likely due to the boundary conditions and assumptions used to treat the epithelium, 
specifically, the distal boundary condition being assigned an insulated boundary and the 
epithelium treatment as a porous media similar to a packed-bed.  I would say that you 
likely want to make the case that the model is representative.  Although the model is an 
idealized representation of physical reality, the overall result is the same, with mass 
transport showing significant differences under different curvatures. 
2.4 Conclusion 
The computational analysis shown here is an assessment of a physics-based model 
calculated through the commercial computational package, Fluent®, to describe the 
concentration of casein within the epithelium as a function of length and radial diameter.  
The model provides an adequate representation of the physical system, yielding valuable 
information about the diseased state.   
The model significantly demonstrates a difference in concentration at the peaks and 
valleys of the esophagus.  This result is observed by Saffari, et al.,15 and appears be a 
cause of excessive concentrations of eosinophils.  This result shows that the curvature of 
the esophagus drives the accumulation of eosinophils in specific areas of the esophagus, 
accelerating a diseased state.  To eliminate, or even reduce, the curvature of the esophagus 
should be explored to minimize the impact of curvature on a diseased esophagus.  This 
could be achieved through the use of a stint-like object that would provide structural 
support to the esophagus. 
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Figure 2.1 – Plot of the eosinophil count collected by Saffari, et al., versus a measurement 
of curvature for a given circumferential location around the esophagus. Data courtesy of 
Hedieh Saffari, University of Utah, 2013 
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Figure 2.3 – Cross-sections of the esophagus in an idealized geometry with (a) large 
undulations, (b) for small undulations for use in computational modeling, and (c) 
micrograph section of the esophagus; pathology slides courtesy of Hedieh Saffari, 




Figure 2.4 – Application of symmetry from the idealized model to the CFD model. 
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Figure 2.5 – Mesh of the model.  The mesh quality parsed the geometry into 
acceptable sections.  The yellow section in this image represents the fluid layer, while the 
grey section represents the epithelial layer. 
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Figure 2.6 – The basic boundary conditions for each of the computational models in 
FLUENT®.  In the model, there are two materials.  The first is the fluid running down the 
esophagus.  The second is the epithelium, shown here as a permeable membrane.  The 
exterior boundaries of the model are set in FLUENT ® as insulated, meaning all of the 
conserved property’s (߰௜) fluxes are zero (e.g., mass fraction of casein, etc.).  The main 
driving force for mass transfer is the boundary conditions at the distal and proximal 
regions of the esophagus. 
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Figure 2.7 – Range of lumen film thickness as a function of the Bond to Capillary 
number ratio.  To generate the curves shown, nominal values of 977	 kg m3⁄ , 9 ൈ
10ିସ	Pa∙s, and 9.81	m s2⁄  for density, viscosity, and acceleration due to gravity are used, 
with 5 ൈ 10ିଽ 	m3 s⁄  and 0.025	m for minimum volumetric flow rate (Q) and esophageal 
perimeter and 5 ൈ 10ି଼ 	m3 s⁄  and 0.06	m for maximum volumetric flow rate (Q) and 




Figure 2.8 – The mass fraction of casein in an epithelium as a function of the location 
within the epithelium with small undulations down the length of the esophagus for the 
thick fluid layer for (a) low porosity (0.215) and (b) high porosity (0.86).  The geometries 
shown are identical, with the only variation being the porosity, thus a significant 
difference in mass fraction along the length of the epithelium is clearly seen. 
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Figure 2.9 – The mass fraction of casein as a function of the location within the 
epithelium with small undulations down the length of the esophagus for the thin fluid 
layer for (a) low porosity (0.215) and (b) high porosity (0.86).  The geometries shown are 
identical, with the only variation being the porosity, thus a significant difference in mass 
fraction along the length of the epithelium is clearly seen. 
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Figure 2.10 – The mass fraction of casein as a function of the location within the 
epithelium with large undulations down the length of the esophagus for the thick fluid 
layer for (a) low porosity (0.215) and (b) high porosity (0.86).  The geometries shown are 
identical, with the only variation being the porosity, thus a significant difference in mass 
fraction along the length of the epithelium is clearly seen. 
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Figure 2.11 – The mass fraction of casein as a function of the location within the 
epithelium with large undulations down the length of the esophagus for the thin fluid 
layer for (a) low porosity (0.215) and (b) high porosity (0.86).  The geometries shown are 
identical, with the only variation being the porosity, thus a significant difference in mass 
fraction along the length of the epithelium is clearly seen. 
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Figure 2.12 – The mass fraction of casein in an epithelium with large undulations down 
the length of the esophagus for the thick fluid layer.  The change in mass fraction profile 
is clearly seen, showing a dependence of curvature on mass transfer. 
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Table 2.1 – Summary of assumptions used in the model. 
Assumption/Parameter Value 
Fluid flow down the esophagus is laminar N/A 
Uniform porosity throughout the epithelium N/A 
The epithelium is treated as a permeable 
membrane N/A 
Model Solver: Pressure Based  N/A 
Zero mass flux along external N/A 
Diffusion Coefficient 1.56 ൈ 10ି଼ 	m2 s⁄  
Casein Molecular Weight 23 
Casein Density 1033 
Casein Inlet Mole Fraction 0.03 
Mesh Skewness <0.85 
Porosity Low: 0.215 High: 0.86 
Density 977 kg m3⁄  
Viscosity 9 ൈ 10ିସ	Pa∙s 
Acceleration due to gravity 9.81	m s2⁄  
Volumetric Flow Rate Min: 5 ൈ 10ିଽ 	m3 s⁄  Max: 5 ൈ 10ି଼ 	m3 s⁄  
Pressure Difference 80 Torr 
Particle Diameter  4 ൈ 10ି଻ m 
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Table 2.2 – Comparison between the center-line integrated mass fractions of casein 









Small  Thick  High  3.51E‐03  3.68E‐03  4.62% Low  3.35E‐03  3.51E‐03  4.56% 
Small  Thin  High  3.86E‐04  4.15E‐04  6.99% Low  3.76E‐04  4.06E‐04  7.39% 
Large  Thick  High  1.91E‐03  2.43E‐03  21.40% Low  1.90E‐03  2.41E‐03  21.16% 
Large  Thin  High  1.27E‐04  1.11E‐04  14.41% Low  1.26E‐04  1.10E‐04  14.55% 
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CHAPTER 3 
A LINEAR MODEL OF EOSINOPHIL GENERATION IN THE ESOPHAGUS 
3.1 Abstract 
Temporal evolution of granule protein concentrations and their putative steady state 
from a biophysical perspective characterizes the pathogenesis of EoE.  It is hypothesized 
that conditions leading to an EoE diseased esophagus can be predicted by analyzing a 
reaction-diffusion model based on an interacting protein network.  This study examines 
the trends that govern the evolution of granule protein concentrations in the epithelial 
layer of the esophagus.  By using a mass transfer version of the lumped capacitance 
method, a determination is obtained that granule protein continues to grow until a steady 
state is reached.  The most significant factors governing granule protein evolution in the 
epithelium yield a series of conditions defining the diseased state. These 
factors/conditions may suggest treatment pathways for EoE patients. 
3.2 Introduction and Background 
A mathematical (systems biology) model for eosinophilic esophagitis (EoE) is 
developed using fundamental transport principles.  The pathogenesis of EoE has been 
analyzed extensively and is a relatively complex biological process.  EoE begins with the 
introduction of an antigen within the esophagus, causing the activation of T-helper cells 
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(Th2), releasing the cytokine interleukin proteins IL-5 and IL-13.1  IL-13 promotes 
epithelial cell repair and causes the production of eotaxin-3 from the epithelial cells.2,3  
Both IL-5 and eotaxin-3 promotes the activation of eosinophils, releasing major basic 
proteins (MBP-1 and MBP-2), eosinophil peroxidase (EPO), eosinophil cationic protein 
(ECP), and eosinophil-driven neurotoxin (EDN).3,4  When activated, eosinophils also 
produce transforming growth factor beta (TGF-β), which continues to activate additional 
epithelial cells and contributes to hyperplasia and fibrosis.5,6  Figure 3.1 is a graphical 
representation of the pathogenesis process as described.   
To generate a mathematical description of the pathogenesis process may be difficult 
and may result in a model that is too unwieldy to be solved or usable.  A simplified 
biological process is adopted to generate a tractable model.  A system of linear mass 
transport and reaction equations are derived using mass transfer first principles.  The 
intent is to determine if the mathematical system described has any inherent instability, 
which can clarify the pertinent parameters for a diseased state. 
3.3 Methods 
In assessing the pathogenesis process outlined in Figure 3.1 and determining the 
significant interactions affecting EoE, certain protein-cell interactions can be neglected 
or integrated into other reactive processes to make a tractable model.  The emphasis of 
the model development is to create a systems biology description, which emphasizes the 
evolution of eosinophil granule protein generation. Currently, interactions only 
influencing eosinophil activation are pertinent.  This approach is taken due to the 
significance of eosinophil granule protein production in defining the EoE diseased state. 
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The transport of the significant species’ concentrations within the esophageal 
epithelium is assumed to be only a function of time and not position.  This assumption 
implies that the concentration gradients in the epithelium are negligible.  This is a 
common practice in heat transfer when the dimensionless quantities are of the appropriate 
magnitude.  This approach is often called a lumped capacitance method and is considered 
a simplified transient conduction model.7  This simplified transient approach performs an 
integral balance of species around a region of interest (i.e., the epithelial layer).  The flux 
of species crossing each boundary is examined, in addition to accumulation within the 
region to give the species within the region of interest throughout time.  
Using a simplified one-dimensional esophagus, shown in Figure 3.2, the lumped 
capacitance method is applied by performing an integral balance around the epithelial 
layer.  The balance for the antigen concentration yields the transport equation 
௘ܸ
݀ܥ஺௘
݀ݐ ൌ ܣ ஺ܰ
௜௡ െ ܣ ஺ܰ௢௨௧ െ ݇௥,஺ ௘ܸܥ஺௘ (3.1)
where ܥ஺௘, ஺ܰ, ܣ, ݇௥,஺, and ௘ܸ are the concentration of the antigen in the epithelium, the 
molar flux into or out of the control volume, the surface area of the epithelium, the 
reaction coefficient of the antigen in the epithelium, and the volume of the epithelium, 
respectively.  First order reactions are utilized throughout the derivation based upon 
observations from Nobuhisa, et al.8 and Humbles, et al.9  The molar flux into the system 
is defined using the mass transfer coefficient formulation,7,10 which becomes 
஺ܰ௜௡ ≡ ݄௖,஺௙ ൫ܥ஺௟ െ ܥ஺௙൯ (3.2)
where ݄௖,஺௙ , ܥ஺௟ , and ܥ஺௙ are the mass transfer coefficient in the luminal film, concentration
of the antigen at the surface of the film, and the concentration of the antigen at the luminal 
film-epithelium interface, respectively. 
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Through the same approach, the flux out of the control volume of the epithelium layer 
is defined as 
஺ܰ௢௨௧ ≡ ݄௖,஺௦ ሺܥ஺௦ െ ܥ஺ஶሻ. (3.3)
Similarly, ݄௖,஺௦ , ܥ஺ஶ, and ܥ஺௦ are the mass transfer coefficient in the submucosa, 
concentration of the antigen at the submucosa–muscular interface, and the concentration 
of the antigen at the submucosa–epithelium interface, respectively. 
The concentration at both sides of the epithelium can be related to the concentration of 
the antigen in the epithelium through the partition coefficient,11 also known as the “K-
value” or “K-factor”, and relates the concentration of a component in one phase to another 




where, ݔሺଵሻ and ݔሺଶሻ are the mole fraction in phase one and the mole fraction in phase 










Thus, the interfacial concentration in the luminal film and submucosa can be related to 
the concentration of antigen in the epithelium. 













ܣ ݇௥,஺ቇ. (3.7) 
Following this pattern described above and assuming that the generation of eotaxin-3 is 
solely attributed to antigen concentration and the generation of granule proteins is solely 
























Eqs (3.7), (3.8), and (3.9) are a series of coupled ordinary differential equations (ODEs) 
and can be solved analytically in a sequential manner.  To facilitate the solution process, 
the above equations are simplified and rewritten to become, 
݀ܥ஺௘
݀ݐ ൌ ߣଵ െ ߣଶܥ஺
௘, (3.10) 
݀ܥଷ௘
݀ݐ ൌ ߣଷ െ ߣସܥଷ
௘ ൅ ߣହܥ஺௘, (3.11) 
and 
݀ܥ௚௣௘
݀ݐ ൌ ߣ଺ െ ߣ଻ܥ௚௣
௘ ൅ ߣ଼ܥଷ௘. (3.12) 
The values of ߣ are defined as 
ߣଵ ൌ ܣ௘ܸ ൫݄௖,஺
௙ ܥ஺௟ ൅ ݄௖,஺௦ ܥ஺ஶ൯, (3.13) 
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ܣ ݇௥,஺ቇ, (3.14) 
ߣଷ ൌ ܣ௘ܸ ൫݄௖,ଷ
௙ ܥଷ௟ ൅ ݄௖,ଷ௦ ܥଷஶ൯, (3.15) 




ߣହ ൌ ௘ܸ݇௥,ଷ, (3.17) 
ߣ଺ ൌ ܣ௘ܸ ൫݄௖,௚௣
௙ ܥ௚௣௟ ൅ ݄௖,௚௣௦ ܥ௚௣ஶ൯, (3.18) 
ߣ଻ ൌ ܣ௘ܸ ቆ݄௖,௚௣
௙ ܭ௚௣௙௘ ൅
݄௖,௚௣௦
ܭ௚௣௘௦ ቇ, (3.19) 
and 
ߣ଼ ൌ ݇௥,௚௣ (3.20) 
Solving the coupled ODEs in eqs (3.10)-(3.12) yields the following solution, 
ܥ஺௘ሺݐሻ ൌ Γଵ,஺൫1 െ ݁ିఒమ௧൯, (3.21) 
ܥଷ௘ሺݐሻ ൌ Γଵ,ଷ൫1 െ ݁ିఒర௧൯ ൅ Γଶ,ଷ൫1 െ ݁ିఒమ௧൯, (3.22) 
ܥ௚௣௘ ሺݐሻ ൌ Γଵ,௚௣൫1 െ ݁ିఒళ௧൯ ൅ Γଶ,௚௣൫݁ିఒళ௧ െ ݁ିఒర௧൯ ൅ Γଷ,௚௣൫1 െ ݁ିఒర௧൯
൅ Γସ,௚௣൫1 െ ݁ିఒమ௧൯. 
(3.23) 
Defining α as 
ߙ ൌ 1ߣଶߣସߣ଻ሺߣଶ െ ߣସሻሺߣ଻ െ ߣଶሻሺߣ଻ െ ߣସሻ, (3.24) 
The coefficients in eqs (3.21)-(3.23) become 
Γଵ,஺ ൌ ߣଵߣଶ, (3.25) 
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Γଵ,ଷ ൌ 1ߣଶߣସሺߣସ െ ߣଶሻ ሺߣଶߣଷߣସ െ ߣଵߣଶߣହ െ ߣଶ
ଶߣଷሻ, (3.26) 
Γଶ,ଷ ൌ ߣଵߣସߣହߣଶߣସሺߣସ െ ߣଶሻ, (3.27) 
Γଵ,௚௣ ൌ ߙሾߣଶߣସߣ଺ሺߣଶଶߣସ െ ߣଶߣସଶ െ ߣଶଶߣ଻ ൅ ߣସଶߣ଻ ൅ ߣଶߣ଻ଶ െ ߣସߣ଻ଶሻ
൅ ߣଶߣସߣ଼ሺߣଶଶߣଷ െ ߣଶߣଷߣସ ൅ ߣଵߣଶߣହ െ ߣଵߣସߣହ
൅ ߣଷߣସߣ଻ሻሿ, 
(3.28) 
Γଶ,௚௣ ൌ ߙߣଶଶߣଷߣସߣ଻ߣ଼, (3.29) 
Γଷ,௚௣ ൌ ߙሾߣଶߣଷߣ଻ߣ଼ሺߣଶߣ଻ െ ߣଶଶ െ ߣସߣ଻ሻ ൅ ߣଵߣଶߣହߣ଻ߣ଼ሺߣ଻ െ ߣଶሻሿ, (3.30) 
and 
Γସ,௚௣ ൌ ߙߣଵߣସߣହߣ଻ߣ଼ሺߣସ െ ߣ଻ሻ. (3.31) 
The solutions given above in eqs (3.21), (3.22), and (3.23) are the time-dependent 
concentration of the antigen, eotaxin-3, and granule protein in the epithelium.  The 
solutions to the transient equations above are variants of the increasing form of the 
exponential decay equation.   
In the increasing form of the exponential decay equation, there exists an asymptotic 
solution as the independent variable goes to infinity.  This implies that there is an 
asymptote as time increases for each of the derived equations.  Taking the limit of eqs 
(3.21), (3.22), and (3.23) as ݐ → ∞ yields the steady state solution for each of the 
components as 
lim௧→ஶܥ஺௘ ൌ Γଵ,஺, (3.32) 
lim௧→ஶܥଷ௘ ൌ Γଵ,ଷ ൅ Γଶ,ଷ, (3.33) 
and 
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lim௧→ஶܥ௚௣௘ ൌ Γଵ,௚௣ ൅ Γଷ,௚௣ ൅ Γସ,௚௣. (3.34) 
The long-term, steady state, solutions given in eqs (3.32), (3.33), and (3.34) allow for 
a parametric assessment of the input parameters to those equations.  Understanding that 
granule protein concentration from the eosinophils is the primary factor driving the 
diseased state, only eq (3.34) is specifically examined across a range of plausible inputs.  
These factors are examined to assess the long-term trends of granule protein 
concentration leading to a diseased state. 
The primary independent variable for the evaluation of eq (3.34) is the antigen 
concentration in the liquid along the epithelial wall, ܥ஺௟ , with the dependent variable being 
the concentration of granule protein in the epithelium, lim௧→ஶܥ௚௣௘ .  To better gauge granule 
protein response to the physical inputs, the inputs are estimated using engineering first 
principles and fundamental assumptions.  The physical inputs deemed to be significant, 
e.g., reaction rate of all the parameters, mass transfer coefficients, and concentration of
each species, are varied to determine how the granule protein concentration changes as 
the physical inputs are perturbed. 
The blood flow removing biological constituents was assumed to be sufficient to 
rapidly remove the species within the submucosa.  Thus, ܥ஺ஶ, ܥଷஶ, and ܥ௚௣ஶ , are assumed 
to be zero.  The mass transfer coefficients are estimated by calculating the diffusion 
coefficients using the Stokes-Einstein equation and the heat and mass transfer analogy 
for a tube bank. This protocol was summarized by Incropera, et al.7 for diffusivity. The 
limiting case uses the transient mass transfer conduction model for the Biot number 
(Bim≈0.1).  A conservative approach to mass transfer along the interfaces of the 
epithelium is implemented by assuming an uninterrupted flow of species across the 
43 
 
epithelial interfaces, thus the thermodynamic factors (i.e., the ܭ values)  in eqs 
(3.14),(3.16), and (3.19) are assumed to be unity.   
The reaction rates are estimated using data provided by Nobuhisa, et al.8 and 
Humbles, et al.9 using the binary reaction rate model as recommended by Fogler.12  The 
initial antigen concentration at the luminal film surface was estimated using the properties 
of casein in milk.13,14  Casein is a family name for related phosphorproteins commonly 
found in mammalian milk.  Casein was chosen due to its history of triggering allergic 
responses. The volume and area of the epithelium are calculated using a typical adult 
esophagus, approximately 25 cm in length,15 and thickness of the epithelial layer of 
approximately 3 mm.16  The physical values of the epithelial layer are kept constant in 
this analysis, while attention is focused on the physical inputs believed to influence 
granule protein mass transfer in the epithelium.  A summary of parameters and 
assumptions is given in Tables 3.1 and 3.2. 
 
3.4 Results and Analysis 
The concentration of granule protein is calculated using eqs (3.32), (3.33), and (3.34).  
To calculate the influence of each parameter on the generation of granule protein, the 
solutions are calculated as a function of the antigen concentration in the luminal film (ܥ஺௟).  
A parametric analysis is performed using the physical values first estimated from the 
information given in Section 3.3 and then perturbing the parameter values by ±50%.  The 
parameters examined in this work focus on reaction rates, concentrations of material at 
the luminal film interface, and mass transport coefficients in the luminal film and 
submucosa.  The mass transport coefficients in eqs (3.12) through (3.20) are calculated 
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using diffusion coefficients and the lumped capacitance mass transfer analogies indicated 
in Section 3.3.  The parametric analysis varies each physical input independently to reveal 
significant trends.  
Figures 3.3 through 3.5 show the concentration of granule protein in the epithelium as 
a function of the antigen concentration in the luminal film when these physical inputs are 
varied.  In general, each perturbation of the inputs had an impact on the concentration of 
granule protein in the epithelium.  Only one parameter, the mass transfer coefficient of 
antigen in the submucosa, did not significantly change the concentration of the granule 
protein in the submucosa and is not shown in this calculation. 
Figure 3.3 shows an increase in granule protein concentration within the epithelium as 
the concentrations of eotaxin-3 and granule protein are increased within the luminal film, 
where the intercept along the granule protein concentration in the figures is more 
impacted by the concentration of eotaxin-3 in the luminal film (Figure 3.3a). Figure 3.4 
shows an increasing trend in granule protein concentration within the epithelium as the 
mass transfer coefficients for eotaxin-3 and antigen are increased in the luminal film. 
Conversely, a decrease in granule protein concentration shows an increase in mass 
transport of granule protein in the fluid.  Figure 3.5 shows an increase for granule protein 
concentration within the epithelium as the mass transfer coefficient for eotaxin-3 in the 
submucosa is increased.  A decrease in granule protein concentration is observed when 
an increase in mass transport of granule protein in the submucosa occurs.  Figure 3.6 
shows an increasing trend in granule protein concentration within the epithelium as the 
reaction coefficients for eotaxin-3 and granule protein are increased, as opposed to a 
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decreasing trend in granule protein concentration with an increase in reaction coefficient 
for antigen. 
In all of the figures cited, a positive, increasing, linear trend is observed.  Depending 
on which input is perturbed, either a change in the granule protein concentration intercept 
(i.e., y-intercept) or the slope is experienced.  The significance of difference in granule 
protein intercept locations is highly dependent on the influence the input has on the 
equations. 
An input that influences the slope and intercept would have the most impact on the 
mass transport of granule protein in the epithelium.  It is clear from the plots that the mass 
transport physical inputs significantly impact the granule protein concentration, 
specifically, the mass transport parameters of the antigen and granule protein in the 
luminal film.  Additionally, all of the reaction rates significantly influence the 
concentration of granule protein in the epithelium. 
Although the perturbations in the physical input’s effect on the intercept and slope 
differ in magnitude and severity, all of the trends are linear and increasing as the 
concentration of antigen is increased.  This result is correct mathematically, but imposes 
very specific physical assumptions on the system.  It would be expected that the 
concentration of granule protein should, at some point, have a decreasing trend when a 
specific key parameter is sufficiently small.  This is shown to not be correct when 
examining the equations as the system approaches a steady state. 
Additionally, the primary assumption used in the lumped capacitance method is valid 
in the ranges of small Biot numbers (Bim<0.1).  This assumption was based on limited 
information concerning the mass transfer and reaction of granule protein in the 
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epithelium.  This model is an acceptable first treatment of a biophysical mass transport 
model driving eosinophilic esophagitis, but a more complete model should be pursued. 
 
3.5 Conclusion 
The analysis described here yields a first assessment of a biophysics-based 
mathematical model to describe the concentration of granule protein within the 
epithelium of the esophagus.  The equations used in this model yield an asymptotic 
solution as the limit of time is taken to infinity, giving a series of steady state equations. 
From these steady state equations, a parametric analysis was performed to explain 
granule protein concentration trends by perturbing the key physical inputs influencing the 
diseased condition. 
The concentration of granule protein in the epithelium linearly increases using this 
steady state model.  The mass transfer of the antigen and granule protein along with all 
of the reaction rates has a significant impact on the slope and intercept of the granule 
protein-antigen linear relationship.  It is believed this is primarily due to the linear 
interaction of these parameters in the transport equations.  The model also presents a 
continually increasing steady state model of the concentration of granule protein.  Even 
when some parameters decrease the transport (e.g., mass transfer of granule protein in the 
luminal film), the slope is never negative. 
Valuable information is obtained through this first effort in defining a mathematical 
representation of the pathogenesis of EoE.  The model does indicate that the mass transfer 
coefficients and reaction rates have a significant impact on long-term growth of 
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eosinophils in the epithelium.  From this evaluation, the main driving force behind EoE 
are the magnitudes of the mass transfer coefficients and reaction rates. 
Key components driving the pathogenesis of a diseased state will eventually diffuse out 
of the epithelium when an adverse stimulus is no longer present.  The equations given 
make the prediction that a continual increase will occur and never reach a state of 
decreasing concentrations.  Also, the linearized transport assumption used in the lumped 
capacitance method may not be adequate to fully describe the diseased state.  A more 
detailed model must be considered to explore the stability of the diseased state and 
determine which parameters have the highest impact. 
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Figure 3.1 – The basic pathogenesis of EoE showing the relation between 
antigen/allergic response and eosinophil granule protein release (courtesy of Rothenberg, 
Gastroenterology, 2009, 137, 1238–1249).  This model is the basis of this study and 
simplifications to this pathogenesis model are made to generate a mathematical model 




Figure 3.2 – A notional one-dimensional model for transient conduction in the esophagus 
with the concentration profiles of a generic biological component, i, shown in the image.  
A control volume (CV) is made around the epithelial layer of the esophagus, where a 
species balance is performed.  The lumped capacitance method assumes the concentration 
of the biological component, i, is constant in the epithelial layer. 
  









Figure 3.3 – Concentration of granule protein in the epithelium as a function of the antigen 
concentration at the luminal film as ݐ → ∞ for (a) concentration of eotaxin-3 in the 
luminal film and (b) concentration of granule protein in the luminal film.  The plots show 
increasing trends in granule protein concentration within the epithelium as the 
concentrations of eotaxin-3 and granule protein are increased.  
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Figure 3.4 – Concentration of granule protein in the epithelium as a function of the antigen 
concentration at the luminal film as ݐ → ∞ for (a) mass transfer coefficient of eotaxin-3 
in the luminal film, (b) mass transfer coefficient antigen in the luminal film, and (c) mass 
transfer coefficient of the antigen in the luminal film.  The plots show positive trends in 
granule protein concentration within the epithelium as the mass transfer coefficients for 
eotaxin-3 and antigen are increased in the luminal film, as opposed to a decrease in 
granule protein concentration with an increase in mass transport of granule protein in the 
fluid. 
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Figure 3.5 – Concentration of granule protein in the epithelium as a function of the antigen 
concentration at the luminal film surface as ݐ → ∞ for (a) mass transfer coefficient of 
eotaxin-3 in the submucosa and (b) mass transfer coefficient of granule protein in the 
submucosa.  A positive trend exists for granule protein concentration within the 
epithelium as the mass transfer coefficient for eotaxin-3 in the submucosa is increased, 
while there is a decrease in granule protein concentration with an increase in mass 
transport of granule protein in the submucosa.  There is no significant impact on granule 
protein concentration for the mass transfer of the antigen in the submucosa and is thus 




Figure 3.6 – Concentration of granule protein in the epithelium as a function of the antigen 
concentration at the liquid surface as ݐ → ∞ for (a) concentration of eotaxin-3 in the 
luminal film edge, (b) concentration of granule protein in the luminal film edge antigen 
reaction rate, and (c) diffusion coefficient of the antigen in the epithelium.  The plots 
show positive trends in granule protein concentration within the epithelium as the reaction 
coefficients for eotaxin-3 and granule protein are increased, as opposed to a decrease in 
granule protein concentration with an increase in reaction coefficient for antigen. 
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Table 3.1 – The calculated values of the physical parameters used in the model.  The 
diffusion coefficients were calculated using Stokes-Einstein’s equation and the reaction 
rates were estimated using data from Nobuhisa, et al.8 and Humbles, et al.9 
Parameter Species Calculated Value 
Diffusion Coef (cm2/s) Antigen 1.564x10-6
Eotaxin-3 4.993x10-6
Eosinophils 6.773x10-6
Reaction Rate (1/s) Antigen/Eotaxin-3 5.794x10-7
Eotaxin-3/Eosinophils 1.786x10-5
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Table 3.2 – A summary of the assumptions made in the development of the model. 
Assumptions 
One-Dimensional in the r-direction 
Constant properties throughout geometry 
Linear concentration changes within the volume 
Biot number is <<0.1 
Reactions are all first order 
Epithelium is a constant matrix of material 
Constant mass fraction of 0.383 for casein entering the system at the 
boundary 
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CHAPTER 4 
DIFFERENTIAL MODEL OF EOSINOPHIL GENERATION IN THE ESOPHAGUS   
4.1 Abstract 
The evolution of eosinophilic esophagitis in the epithelium is heavily dependent on 
the physical transport parameters dictating the pathogenesis of the disease.  It is 
hypothesized that the conditions leading to a disease (versus normal) state of an 
esophagus can be predicted by analyzing a differential reaction-diffusion model for EoE 
based on an interacting protein network.  This study examines the influence of the 
physical parameters governing both the mass transfer and reaction network on granule 
protein concentrations within the epithelium.  Through the use of computational 
experiments, continual growth trends occur as physical parameter magnitudes increase.  
A Plackett-Burman screening design of experiments is completed to identify significant 
parameters governing mass transfer evolution.  The significant parameters governing 
granule protein evolution in the epithelium suggest treatment pathways for EoE patients. 
4.2 Introduction and Background 
In the pursuit of a biophysical description for eosinophilic esophagitis (EoE), a 
mathematical (systems biology) model is developed using fundamental transport 
principles, similar to what was performed in Chapter 3.  Following the same approach to 
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pathogenesis, as in Chapter 3, EoE begins with the introduction of an antigen within the 
esophagus, causing the activation of T-helper cells (Th2), releasing the cytokine 
interleukin proteins IL-5 and IL-13.1  IL-13 promotes epithelial cell repair and causes the 
production of eotaxin-3 from the epithelial cell.2,3  Both IL-5 and eotaxin-3 promote the 
activation of eosinophils, releasing major basic proteins (MBP-1 and MBP-2), eosinophil 
peroxidase (EPO), eosinophil cationic protein (ECP), and eosinophil-driven neurotoxin 
(EDN).3,4  When activated, eosinophils also produce transforming growth factor beta 
(TGF-β), which continues to activate additional epithelial cells and contributes to 
hyperplasia and fibrosis.5,6  Figure 4.1 is a graphical representation of the pathogenesis 
process as just described. 
Here, a slightly more complex mass transport process is approached.  Using the 
principles of differential mass balances, a system of linear partial differential equations, 
describing the mass transport and reaction equations, is derived.  These model equations 
are analyzed to determine inherent instability.  The equations are also assessed using 
computational experimentation using a pseudo Monte Carlo method and design of 
experiments to identify significant trends in the estimated parameters.  The parameteric 
assessment identifies the factors most significantly impacting the concentration of 
granule proteins within the epithelium. 
4.3 Methods 
A model to describe the migration of granule proteins from eosinophils is achieved 
by using a differential approach to the mathematical model for species conservation of 
granule protein generation.  The previous analysis, in Chapter 3, made significant 
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assumptions in the system, most significantly, neglecting nonlinear variability in 
concentration throughout the esophagus and the relation between antigen, eotaxin, and 
granule protein concentrations.  Relaxing these assumptions provides a convenient 
solution, but no significant insight is gained about a diseased condition. 
Through the species conservation approach, the conditions where the system would 
be stable or unstable are reached by performing a classical linear stability analysis.7  
Additionally, a nondeterministic modeling approach, where variable input parameters are 
used to generate pseudo-random output results, is used to examine the parameter trends.  
The Latin Hypercube Sampling (LHS)8 method is used to generate a pseudo-random 
range of input parameters, generating an array of pseudo-random outputs.  In utilizing a 
nondeterministic approach, trends can be determined that lead to the effect parameters 
will have on the output of the chemical diffusion reaction system. 
A significant weakness to the nondeterministic approach is predictions are only 
as reliable as the prior information used.  If no data are present, a model calibration 
cannot be reached and the model is a prediction of the expected outcome defined by the 
model equations.  To determine the sensitivity of the model inputs to the given 
outputs, a Plackett-Burman9 sensitivity analysis is executed.  The Plackett-Burman 
analysis is a general method that can be utilized to provide insight as to which 
parameters significantly contribute to a diseased esophagus. 
4.3.1 Esophagus Model Definition 
To generate a more sophisticated model, the linear assumptions outlined in Chapter 3 
are removed from the derivation.  Following the same pathogenesis process outlined in 
Chapter 3 with the antigen-eotaxin-3-granule protein interaction simplification, the 
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equations are derived for the region of the epithelial layer in the esophagus. EoE primarily 
is manifest in the epithelium and only this region is examined in this assessment. 
Applying a general species mass balance to a control volume around the epithelium (see 
Figure 4.2), the system is described by,  
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߲ݎ ቇ൱ ൅ ߶ଶ߱௘௢ଷ, (4.3) 
and for the granule protein, where ߱, ܦ, ߶, ݎ, and ݐ, are mass fraction, diffusion 
coefficient, reaction rate, radial position, and time, respectively. 
Assuming a constant concentration of antigen for a given length of time, in addition 
to a linear flux of species out of the epithelium for all species into the blood stream, the 
boundary conditions become, 
ە
۔
ۓ߲߱௜߲ݎ ฬ௥ୀ௅ ൌ ݄ሺΔ߱௜ሻ
߲߱௜
߲ݎ |௥ୀ଴ ൌ 0
(4.4) 
and 
߱஺ሺݐ, 0ሻ ൌ ߱஺,௢, (4.5) 
where ܮ is the maximum radial thickness of the esophagus.  Eqs (4.1) through (4.3) define 
the transport in the epithelium, while the conditions defined in eqs (4.4) and (4.5) give 
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the initial and boundary conditions resulting in antigen exposure and the flux of species 
due to blood flow at the epithelial wall. 
4.3.2 Linear Stability Analysis 
The analytical solutions to eqs (4.1) through (4.3) are not easily obtainable.  
Alternative methods to assess the system’s behavior can be obtained by using methods 
from hydrodynamic stability.7,10,11  The key concept with hydrodynamic stability is 
examining a stationary system under an infinitesimal perturbation.  Under this 
perturbation, the system will exhibit specific characteristics.   
When the system is disrupted, three characteristic behaviors may occur.  If a perturbed 
system reacts with a diminishing response for all inputs the system is characterized as 
stable.  If the amplitude of a system’s response increases for all inputs, such that a 
progressive departure from the stationary state occurs, the system is characterized as 
unstable.  When the system’s response diminishes for some inputs and departs from the 
stationary state for other inputs, the system is considered marginally stable.11  Application 
of hydrodynamic stability methods can be applied to a wide variety of applications.  
Although the physics involved in defining a system may be different from 
hydrodynamics, the mathematics are similar and the same methods can be applied.7 
The most fundamental approach to hydrodynamic stability is to use a linear or weakly 
nonlinear stability analysis.7  In linear stability analysis, the equations defining the 
physics of a system are linearized for small perturbations.7  To begin this process for 
assessing EoE disease, the solutions to eqs (4.1), (4.2), and (4.3) are assumed to be a 
linear combination of a steady state solution and a perturbed solution,  
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߱௜ ൌ ഥ߱௜ ൅ ෥߱௜. (4.6) 
Typically, the stability of a system is assessed against the steady state solution under small 
perturbations.7  Through this assessment, the growth or decay in the perturbation can be 
ascertained. 
For a complete analysis to be performed, the analytical solution for the steady state 
condition is recommended.  Due to the coupled nature of the equations used to describe 
EoE in Section 4.3.1, an analytical form for the steady state solution does exist.   
Although the analytical steady state solution cannot be utilized for a complete 
analysis, the equations can be simplified to examine only the unstable components in eq 
(4.6).  This approach is ideal when the profile under small perturbations (e.g., 
concentration profile) is of no concern and the analysis is focused under conditions the 
equations would be stable or unstable.  Thus, to determine the perturbed state, only the 
perturbed operator is required.10 
The perturbation analysis begins by nondimensionalizing eqs (4.1), (4.2), and (4.3) to 
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߲ݎ∗ ቇ൱ ൅ ߶ଶ߬ ௚߱௣. (4.9) 
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where, ߬ and ܮ are the characteristic time and length, respectively.  Similarly, the steady 
state equations are defined for antigen by, 






߲ݎ∗ ൰൱ െ ߶ଵ߬ ഥ߱஺, (4.10) 
for eotaxin-3 by, 
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and for granule protein by, 






߲ݎ∗ ቇ൱ ൅ ߶ଶ߬ ഥ߱௚௣. (4.12) 
The linear combination in eq (4.6) is inserted into eqs (4.7), (4.8), and (4.9), and steady 
state terms are eliminated by subtracting the steady state equations eqs (4.10), (4.11), and 





















߲ݎ∗ ൰൱ ൅ ߶ଵ߬ ෥߱஺ െ ߶ଶ߬ ෥߱௚௣, (4.14) 










߲ݎ∗ ቇ൱ ൅ ߶ଶ߬ ෥߱௚௣. (4.15) 
Eqs (4.13), (4.14), and (4.15) are the perturbed state of the EoE system defined in Section 
4.3.1. 
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To examine the stability, a complex growth operator is selected to identify normal 
modes in the system.  Traditionally, the complex operator is assumed to be a linear 
superposition of imaginary exponential equations.  This is not a practical approach with 
these equations due to the cylindrical coordinate system from the esophagus.  Through 
the Bessel function of the first kind,12 the perturbation for the i-th species is given by, 
෥߱௜ ൌ ܣ௜,௢݁௠൫ೖሬԦ൯௧ܬ௢ሺ݇௥ݎሻ, (4.16)
where ሬ݇Ԧ ൌ ሺ݇ଵ, ݇ଶ, … ሻ is the wave vector, pointing in the direction of the wave 
propagation, and ݉൫௞ሬԦ൯ is the growth rate of the wave.   




ଶݔଶ െ ߥଶሻ ൌ 0, (4.17) 
to evaluate the cylindrical coordinate derivative of the Bessel function of the first kind in 





߲ݎ ܬ௢ሺ݇௥ݎሻ൰ ൌ െܣ௜,௢݉
ሺ௞ሻ݇௥ଶܬ௢ሺ݇௥ݎሻ݁௠ሺೖሻ௧, (4.18) 
where ݇ is the magnitude of the wave vector, or generally, the wave number.13  Only the 
magnitude of the wave vector is considered since the direction of propagation does not 
matter in this analysis.  Inserting eq (4.18) into eqs (4.13), (4.14), (4.15), and simplifying 
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must be satisfied.  From eq (4.19), the growth rate is defined through the characteristic 
equation,  
൬െܦ஺߬ܮଶ ݇௥
ଶ െ ߶ଵ߬ െ ݉ሺ௞ሻ൰ ൬െܦ௘௢ଷ߬ܮଶ ݇௥
ଶ െ ߶ଶ߬ െ ݉ሺ௞ሻ൰
൬െܦ௘௢ଷ߬ܮଶ ݇௥
ଶ െ ݉ሺ௞ሻ൰ ൌ 0.
(4.20) 














The stability of the system is defined through the magnitude of the growth rate.  The 
growth rate can be defined in terms of real and imaginary components.  For this 
assessment, only the magnitude of the real component is of importance.  If instability is 
present in the system, the growth rate must be positive for at least one wave number.  
Stability is present when the real component of the growth rate is negative for all wave 
numbers. 
In eq (4.21), all of the possible solutions to the growth rate are negative, meaning the 
system is unconditionally stable.  This result holds true for multiple dimensions.  Only a 
negative diffusion coefficient for any one of the species examined through this model 
would cause instability, resulting in an accumulation of eosinophils in the esophagus, 
leading to a diseased state. 
The physical phenomena of negative diffusion is possible in nature and is a result of 
interparticle interactions or various thermodynamic forces.14,15  These typically result in 
either spinodal decomposition16 or first order phase transition by nucleation.14  In the case 
of spinodal decomposition, like species are highly attracted to one another.  This 
attraction is significant enough to cause a flux in the direction up the gradient, giving a 
diffusion coefficient which is effectively negative.  Spinodial decomposition typically is 
manifest macroscopically as packets of “concentration waves”.16  In the case of 
nucleation, phase concentration is reduced in the immediate location of a growing 
particle.14  The components feeding the nucleation process flow through a normal 
diffusion process, down the concentration gradient, but a negative concentration gradient 
occurs in the global frame of reference.14  Nucleation results in particle growth and 
coalescence, which may occur in all phases of material. 
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In either process of negative diffusion, no significant research has proven eosinophils, 
or any of the other biophysical components in eosinophilic esophagitis, resemble either 
spinodal decomposition or nucleation characteristics.  Without evidence of negative 
diffusion, a parametric study of eqs (4.1), (4.2), and (4.3) is sought to better understand 
the influence of the physical parameters on mass transfer. 
4.3.3 Nondeterministic Computational Modeling 
In assessing the pathogenesis process outlined in Figure 4.1 and determining the 
significant interactions affecting EoE, certain protein-cell interactions can be neglected 
or integrated into other processes to make a tractable and discernable model.  The 
emphasis of the mathematical model development is to create a systems biology 
description, which emphasizes the evolution of eosinophil granule protein generation, 
thus interactions only influencing eosinophil activation are pertinent.  With an analytical 
solution being impractical, if not impossible to obtain, a computational solution is needed. 
Generally speaking, any description of a physical system may be summarized in the 
form of, 
ݕ ൌ ܯሺ࢞ሻ, ࢞ ൌ ሺݔଵ, … , ݔ௦ሻᇱ ∈ ௦ܸ, (4.22) 
where ࢞ is the vector of input variables, ݕ is the solution via analytical or numerical 
methods, the function ܯ is the model describing the system, and ௦ܸ is the input variable 
space.  In scientific investigation, the ability to understand the relationship between the 
system’s response, ݕ, and a given set of inputs, ࢞, is needed to make informed decisions 
about the system.17,18 
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If the relationship between inputs and outputs are explored experimentally, the 
resulting tests may be costly and potentially prohibitive to execute.  Significant research 
has been performed to explore more efficient approaches to minimize the burden of 
physical experimental studies while maximizing the information gain.  Thus, alternative 
approaches using models to explore a system’s relationships are more desirable due to 
the limitations of physical experiments. 
With the development of more efficient computers, numerical methods have become 
a critical component in scientific exploration.  A model given by eq (4.22) is often 
difficult to solve analytically and one must typically resort to computational methods to 
determine an approximate solution.  Through in silico experimentation, these 
relationships can be examined and valuable information can be obtained easily, but can 
quickly become burdensome if the system is too complex.  Consequently, a primary 
objective in computer experimentation is to find a system definition that is simple enough 
to compute a solution while simultaneously providing an adequate description of the 
physics. 
In silico experiments are very powerful because large numbers of input variables can 
be explored simultaneously.  A significant challenge with the numerical solution to eq 
(4.22) is that the solution is deterministic, in which the solution for a given set of inputs 
will always produce a specific set of outputs. 
To overcome the challenge of determinism within a numerically determined solution, 
additional processing of the input variables can be performed to create a non-
deterministic algorithm.  The most common approach to processing of the input variables 
is to introduce randomness into the input variables.19  The process of introducing 
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randomness can be performed in several ways, but can give significant information as to 
the basic characteristics of the system.  The process of in silico experimentation provides 
unique abilities and requires special attention to the experimental design approach to 
produce beneficial information. 
In this work, a Latin Hypercube Sampling (LHS) algorithm is used to randomized the 
inputs.  LHS was proposed by McKay, Beckman, and Conover in 19798 and is considered 
as the seminal paper in the design of computer experiments.17  If the inputs into the 
computational model are not precisely known, but a range of values can be postulated, 
either through statistical interpretation or estimation, LHS is an ideal method.  LHS 
divides the domain of all plausible variables into n strata of equally probable and uniform 
intervals.  The variable intervals are arranged to create a multidimensional cube (a.k.a., a 
Latin hypercube) of equally probable interval intersections. The interval intersections are 
selected pseudo-randomly to ensure only one intersection is selected for all rows and 
columns defining the variables’ plausible range.  With the intersection now chosen, 
discrete values are then selected at random within each intersection. 
As an example, assume the LHS method is applied to two variables.  The first step in 
LHS divides the range of each variable into ݊ ൌ 5 intervals.  The strata of variables are 
then arranged with one variable (ݑ) along the x-axis and the other (ݒ) along the y-axis of 
the domain.  Intersections are selected pseudo-randomly to ensure no other intersections 
can be chosen in the same row and column of the current selection.  With each selected 
interval, a discrete value is used for computation.  Figure 4.3 shows an example of this 
process. 
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LHS is utilized to examine parameter correlations from eqs (4.1), (4.2), and (4.3).  A 
time-dependent solution is calculated computationally using the finite difference methods 
outlined by Patankar20 and Ferziger.21  In the calculation, the esophagus is exposed to a 
constant concentration of antigen for 30 minutes.  The diffusivities and reaction rates in 
eqs (4.1), (4.2), and (4.3) are varied giving four different parameters to compare against 
each concentration.  
Similar assumptions are used to determine initial parameter values from Chapter 3.  
The mass transfer coefficients are estimated by calculating the diffusion coefficients 
using the Stokes-Einstein equation and the heat and mass transfer analogy for a tube bank 
as summarized by Incropera, et al.22 for diffusivity.  The reaction rates are estimated using 
data provided by Nobuhisa, et al.23 and Humbles, et al.24 to a linear reaction rate model 
recommended by Fogler.25  The initial antigen concentration at the luminal film surface 
was estimated using the properties of casein in milk.26,27  The calculated values (shown 
in Table 4.1) were varied significantly by several orders of magnitude to yield a wide 
range of potential responses.  Table 4.2 summarizes the assumptions made in the 
development of the model. 
4.3.4 Plackett-Burman Sensitivity Analysis 
A weakness of the LHS algorithm is it does not intuitively determine the impact of 
each input parameter on the overall output of the concentration profiles.  To determine 
the significance of each parameter on the outcome of the model, a different computer 
experiment method is needed, in which the primary purpose is to “screen-out” the 
important parameters, or factors, from the less important ones.  This type of experiment 
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is typically used for physical experiments, but can also be utilized for computational 
experiments, where the screened results can give better direction in future physical 
experimentation.  
A common screening design is the full factorial experiment design.  This design gives 
a complete picture of the importance of each factor in addition to the influence on 
interacting factors.  The primary disadvantage of a sophisticated experimental design like 
a full factorial approach is that as one increases the total number of factors analyzed, the 
total number of experimental runs (i.e., observations) will increase as ܮ௞, where ݇ is the 
number of effects and ܮ is the number of levels for each factor.  Thus, for an experiment 
with two levels (i.e., a “high” and a “low” value) and six factors, the total number of 
observations would need to be 2଺ ൌ 64, which is not ideal in a physical or computational 
experiment.28 
Additional designs may be performed that will decrease the overall number of 
observations and are more ideal in an experiment where there are several factors being 
considered.  One such design is the Plackett-Burman screening design.  Originally 
developed in 1946 by statisticians Robin L. Plackett and J.P. Burman,9 it is a screening 
method that efficiently identifies the active factors of a system using as few experimental 
runs as possible.  For two factor levels, the minimum number of observations required 
must be a multiple of four instead of a power of two for full and partial factorial designs. 
A Plackett-Burman experimental design is used to identify main factors within a 
system.  Due to the properties of a Plackett-Burman design, the main factors are estimated 
independently of each other, thus interacting effects between factors are not considered.   
Therefore, the Plackett-Burman design is used to study main effects.  Since this study is 
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only concerned with main responses and not interactions, a two-level Plackett-Burman 
experiment is used for all of the variable parameters in the model.  Table 4.3 shows the 
Plackett-Burman experimental design for this work.   
To assess the contribution of each parameter in the Plackett-Burman design, the 
contributions of each factor are evaluated in terms of a parameter called the contrast.  The 
contrast is a variable that can be used to compare two or more factors by examining their 






which is subject to the condition that the coefficients, ௝ܿ, sum to zero. 
Values of the contrast are obtained for each of the factors at a given response (e.g., 
integrated concentration, mean value, maximum value, etc.).  To compare the contrast of 
each factor, the sum of squares for the contrast is calculated, i.e.,  
ܵܵ൫ܥመ൯ ൌ ܥመ
ଶ
݊ . (4.24) 
where ܵܵ൫ܥመ൯ is the sum of squares for the contrast, and ݊ is the number of observations. 
The sum of squares for the contrast for each factor and response is compared to 
determine the significance of each factor in the system.28  Since the magnitudes of each 
concentration differ significantly, the responses for the sum of squares for the contrast 
are normalized against the largest magnitude of the sum of squares.  Through comparing 
the normalized values for the sum of squares of the contrast, the Plackett-Burman design 
“screens-out” parameters that are important against parameters that do not impact the 
physical system under consideration. 
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Using the same mean parameters and solution method given in Section 4.3.3, the 
time-dependent solution is determined.  To provide the positive and negative conditions 
needed for the Plackett-Burman approach shown in Table 4.3, the parameters were varied 
±50%.  The model was calculated for each observation and concentration profiles were 
collected.  The integrated and maximum concentration for each species is used as the 
system response quantity.  
4.4 Results and Analysis 
From the equations describing EoE transport and reaction in the epithelium, the mass 
fraction of each species is calculated over the length of the epithelium.  The LHS analysis 
is performed by varying from the nominal parameters calculated (see Table 4.1) and 
repeating the calculation 500 times with an array of pseudo-random parameters.  Figure 
4.4 shows one example of a profile from that array.  To compare the relative outcomes as 
a function of the mass fraction of the species, each profile is integrated and compared to 
the parameters used to create the output.  Figures 4.5 through 4.10 show the various 
integrated profiles as a function of the parameter value used to generate the profile. 
A strong correlation exists between the antigen diffusion and the integrated mass 
fractions of antigen (Figure 4.5a), eotaxin-3 (Figure 4.7a), and granule proteins (i.e., 
eosinophils) (Figure 4.9a).  This is manifest by a discernible logarithmic growth trend in 
each of the figures.  Antigen has the most significant correlation, although this is primarily 
due to the nature of the boundary condition, changes in mass fraction profiles, and the 
antigen diffusion coefficient. 
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The diffusion coefficients for eotaxin-3 and eosinophils do not have a significant 
impact on the model’s outputs.  The pathogenesis is linear, requiring an initial prime 
mover, the antigen, to start the process.  Without the transport of antigen into the 
epithelium, no other species materialize.  Thus, a strong correlation should be expected 
between the antigen diffusion and the mass fraction profiles of the other species in the 
epithelium. 
There is a strong correlation between the reaction rate for antigen-eotaxin-3 reaction 
rate, ߶ଵ in eqs (4.1) and (4.2), and the mass fraction of eotaxin-3 (see Figure 4.8a).  
Additionally, a three-way correlation also occurs between the rate for antigen-eotaxin-3 
reaction and the eotaxin-3-eosinophil reaction rate, ߶ଶ in eqs (4.2) and (4.3), and the 
eosinophil mass fraction within the epithelium (see Figure 4.10).  This is manifest in a 
more linear growth, showing constant growth in the mass fractions as reaction rates 
increase. 
From the LHS assessment, the increase in the magnitude of specific parameters 
resulted in the emergence of a consistent and continual growth pattern.  Thus, it is 
important to understand what physical parameters have a significant impact on the mass 
fraction profiles within the epithelium.  Performing the Plackett-Burman screening test 
on the system, the sum of squares of the contrast for each parameter can be identified and 
compared. 
Figures 4.11 and 4.12 show the normalized sum of squares of the contrast for each 
species and physical parameter.  The normalized maximum mass fraction within the 
epithelium is shown in Figure 4.11.  The maximum mass fraction is not shown for antigen 
because the maximum value occurs at the boundary condition and is unchanged 
76 
 
throughout the analysis.  The Plackett-Burman analysis shows that the only significant 
responses in the pathogenesis of EoE are reaction rate coefficients (߶ଵ and ߶ଶ) for the 
mass fractions for eotaxin-3 and granule proteins in the epithelium. 
The normalized integrated mass fraction is shown in Figure 4.12.  This result differs 
slightly from the maximum concentration, which allows for the inclusion of the antigen 
mass fraction responses.  Significantly, the main diffusion response occurs only for 
antigen diffusivity for each of the species, with the most significant response being 
between the integrated antigen mass fractions.  The reaction rates also have a significant 
impact on the integrated mass fractions for eotaxin-3 and granule proteins, similar to the 
maximum concentration outcome.  These results correlate with the LHS result shown in 
Figures 4.5 through 4.10, but with the benefit of a weighting scale on which the 
significance of each parameter may be placed. 
 
4.5 Conclusion 
The analysis performed here provides a differential assessment for a conservation-
based biophysical model to describe the concentration of eosinophils within the 
epithelium of the esophagus.  A linear stability analysis was performed on the equations 
describing the transport of the main components, antigen, eotaxin-3, and granule proteins 
from the eosinophils.  Linear stability analysis showed that the equations describing the 
system were unconditionally stable.  This stability implied a constant growth of 
concentrations within the epithelium without the interaction from alternative phenomena, 
like thermodynamic forces. 
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Without evidence indicating thermodynamic phenomena, like spinodal 
decomposition or interparticle interactions, it is safe to assume increasing parameter 
values would cause increasing concentrations of granule proteins within the epithelium.  
A parametric analysis to yield parameter growth interactions on the mass fraction outputs 
was completed using LHS, a pseudo Monte Carlo method of parameter exploration. 
The LHS analysis showed key parameters, which highly influence the mass fraction 
of species within the epithelium.  Antigen diffusion appeared to be the only transport-
specific parameter affecting the mass fraction of all the species within the epithelium, due 
to the fact that antigen is a marker to promote the response and activation of eotaxin-3 
and granule proteins in the pathogenesis process.  This phenomenon resulted in a 
logarithmic increase in concentration as the diffusion coefficient is increased.  Reaction 
rates have a discernable impact on the mass fraction profiles of eotaxin-3 and the granule 
protein, which resulted in a linear increase as the reaction rates are increased. 
To quantify the significance of parameter influence on the transport equations, a 
Plackett-Burman screening test was completed.  Plackett-Burman screening tests provide 
a method to determine the significant parameters within an experiment, thus screening 
trivial information from the significant factors.  Performing a computational factorial 
experiment using the Plackett-Burman method determined the significant parameters 
affecting the diseased state of EoE.  The reaction rates of antigen-eotaxin-3 and eotaxin-
3-granule protein were the most significant factors driving the presence of granule
proteins within the epithelium. 
The results from the Plackett-Burman analysis reflect what is observed in the LHS 
study.  If the equations used to describe the pathogenesis are correct and are stable, a 
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continual increase in the concentration of granule protein is expected.  Thus, to prevent a 
diseased condition, one must determine a way to retard or halt the activation of 
eosinophils from markers like eotaxin-3 or determine a way to prevent the transport of 




Figure 4.1 – The basic pathogenesis of EoE showing the relation between 
antigen/allergic response and eosinophil granule protein release (courtesy of Rothenberg, 
Gastroenterology, 2009, 137, 1238–1249).  This model is the basis of this study and 
simplifications to this pathogenesis model are made to generate a mathematical model 





Figure 4.2 – A notional one-dimensional model for transport of species in the 
epithelium of the esophagus with the expected concentration profile of a generic 
biological component, i, shown in the image.  A control volume (CV) is made around the 
epithelial layer of the esophagus, where a species balance is performed. 
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Figure 4.4 – The mass fraction of (a) antigen, (b) eotaxin-3, and (c) eosinophils as a 





Figure 4.5 – Integrated antigen mass fraction as a function of the (a) antigen diffusion 
coefficient, (b) eotaxin diffusion coefficient, and (c) eosinophil diffusion coefficient.  A 
logarithmic growth pattern can be observed in the mass fraction as a function of the 
antigen diffusion coefficient.  The impact of this parameter is due to the serial nature of 
the mass transport equations derived in the pathogenesis of EoE.  The high correlation is 
also due to the fixed boundary condition of the antigen coming into the epithelium.  The 
lack of correlation in (b) and (c) indicates a poor correlation between the parameter and 
the output of the model.  The similarity of these images to a “scatter” plot implies no 
correlation. 
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Figure 4.6 – Integrated antigen concentration as a function of the (a) the antigen-
eotaxin-3 reaction rate (i.e., ߶ଵ) and (b) the eotaxin-3-eosinophil reaction rate (i.e., ߶ଶ).  
No significant correlation is observed, although a slight decrease can be seen with the 
antigen-eotaxin-3 reaction rate, which is not significant enough to be considered relevant. 
The lack of correlation in (a) and (b) indicates a poor correlation between the parameter 





Figure 4.7 – Integrated eotaxin-3 mass fraction as a function of the (a) antigen 
diffusion coefficient, (b) eotaxin-3 diffusion coefficient, and (c) eosinophil diffusion 
coefficient.  A logarithmic growth pattern can be observed in the mass fraction as a 
function of the antigen diffusion coefficient.  The impact of this parameter is due to the 
serial nature of the mass transport equations derived in the pathogenesis of EoE. The lack 
of correlation in (b) and (c) indicates a poor correlation between the parameter and the 






Figure 4.8 – Integrated eotaxin-3 concentration as a function of the (a) the antigen-
eotaxin-3 reaction rate (i.e., ߶ଵ) and (b) the eotaxin-3-eosinophil reaction rate (i.e., ߶ଶ).  
A significant correlation is observed for the antigen-eotaxin-3 reaction rate, which 
manifests in a linearly increasing integrated mass fraction of eotaxin-3.  The lack of 
correlation in (b) indicates a poor correlation between the parameter and the output of the 





 Figure 4.9 – Integrated eosinophil mass fraction as a function of the (a) antigen 
diffusion coefficient, (b) eotaxin-3 diffusion coefficient, and (c) eosinophil diffusion 
coefficient.  A logarithmic growth pattern can be observed in the mass fraction as a 
function of the antigen diffusion coefficient.  The impact of this parameter is due to the 
serial nature of the mass transport equations derived in the pathogenesis of EoE.  The lack 
of correlation in (b) and (c) indicates a poor correlation between the parameter and the 




Figure 4.10 – Integrated eosinophil mass fraction vs. the reaction rate of (a) the 
antigen-eotaxin-3 reaction rate (i.e., ߶ଵ) and (b) the eotaxin-3-eosinophil reaction rate 
(i.e., ߶ଶ).  A significant correlation is observed for the antigen-eotaxin-3 and the eotaxin-
3-eosinophil reaction rate, which manifests in a linearly increasing integrated mass




Figure 4.11 – Summary of the sum of squares of the contrast for the maximum mass 
fraction for each parameter within the epithelium.  The most significant parameters using 
this response quantity are the reaction rates for the antigen-eotaxin-3 (i.e., ߶ଵ) and the 



































Figure 4.12 – Summary of the sum of squares of the contrast for the integrated mass 
fraction for each parameter within the epithelium.  The most significant parameters using 
this response quantity are the diffusion of antigen and the reaction rates for the antigen-



































Table 4.1 – The calculated values of the physical parameters used in the model.  The 
diffusion coefficients were calculated using Stokes-Einstein’s equation and the reaction 
rates were estimated using data from Nobuhisa, et al.23 and Humbles, et al.24 
Parameter Species Calculated Value 
Diffusion Coef (cm2/s) Antigen 1.564x10-6 
Eotaxin-3 4.993x10-6 
Eosinophils 6.773x10-6 





Table 4.2 – A summary of the assumptions made in the development of the 
computational model. 
Assumptions 
One-Dimensional in the r-direction 
Constant properties throughout geometry 
Flux between elements in discrete geometry is first order an changes 
minimally over time 
Reactions are all first order 
Epithelium is a constant matrix of material 
Constant concentration of antigen at the boundary 
Time dependent, calculated profiles for 30 minutes of constant exposure 
Flux out of the epithelium assumed to be analogous to mass transfer in a 
tube bank with flux estimated as 5.26 ൈ 10ି଼ m/s for antigen, 6.73 ൈ 10ି଼ 
m/s for eotaxin-3, and 8.51 ൈ 10ି଼ m/s for granule protein. 
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Table 4.3 – The Plackett-Burman design used to analyze the sensitivity of parameters 
in the Eosinophilic Esophagitis computational model.  A high value is denoted as a “൅” 
symbol and a low value is denoted as a “െ” symbol in the table.  For this study, only eight 




A (DAntigen) B (DEO3) C (DEosinophils) D (kAntigen) E (kEosinophils)
1 - - - + +
2 + - - - -
3 - + - - +
4 + + - + -
5 - - + + -
6 + - + - +
7 - + + - -
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CHAPTER 5 
RELEASE OF PHARMACEUTICAL COCKTAILS FROM SMALL POLYMER 
MICELLES CONTROLLED BY THERMODYNAMICS 
5.1 Abstract 
Most emerging anti-cancer agents remain sparingly soluble in water, so they require 
carriers such as poly(ethylene glycol)-block-poly(D,L-lactic acid) (PEG-b-PLA) micelles 
to enhance their delivery.  Shin, et al. used these micelles as vectors for combinations of 
three hydrophobic cancer drugs (paclitaxel, 17-allylamino-17-demethoxygeldanamycin, 
and rapamycin) to empirically determine that the half-life of agent release is a function 
of the oil-water partition coefficient. This is in contrast to their assertion that the cocktail 
release rate is diffusion controlled.  We determine this unexpected, yet important, result 
using a lumped capacitance method.  The proposed model provides excellent agreement 
with experimental release profiles provided by Shin, et al. indicating that the release rate 
is not controlled by simple diffusion.  The model finds that the half-life is a function of 
the micelle radius, external mass transfer coefficient, and lumped partition coefficient. 
This explains the apparent dependence of the release rate profile on the oil-water partition 
coefficient.  These findings simplify design and enable tuning the release of multidrug 
mixtures from micelles, which will be increasingly important since many new drug 
candidates are hydrophobic macromolecules. 
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5.2 Introduction and Background 
Advances in combinatorial chemistry and high throughput screening have 
accelerated the discovery of therapeutic agents.  Although the use of these methods allows 
rapid evaluation of a wide array of drug candidates, a growing number of these molecules 
remain poorly water-soluble with limited bioavailability.1  Effective therapies must be 
soluble, release appropriately, and have excellent biodistribution.2  Therefore, significant 
research has focused on the development of carriers to enhance the solubility of poorly 
water-soluble pharmaceutical agents.   
Further complicating matters is an emerging trend in cancer therapy to combine 
pharmaceuticals to target multiple tumorigenic pathways to overcome drug resistance and 
tumor heterogeneity.3-5  Delivery of these potent yet poorly water-soluble drugs may be 
enhanced by low-molecular-weight surfactants (e.g., synthetic Kolliphor EL may be 
incorporated to stabilize nonpolar emulsions) to improve solubilization.2,6  However, the 
use of these excipients may induce cytotoxicity and accentuate drug instabilities.7  
Improved encapsulation methods remain essential for effective delivery of combinatorial 
drug treatments. 
Polymeric micelles remain promising because they are versatile and have been 
used as drug carriers for decades.2,8-16  These spheroidal structures form by self-assembly 
of amphiphilic block copolymers in aqueous environments into a hydrophobic core and 
a hydrophilic shell (see Figure 5.1).2,17  The micelle’s core serves as a micro-reservoir to 
encapsulate hydrophobic molecules, while the hydrophilic shell interfaces with biological 
media.  Variations in micelle-forming chemistry facilitate customization of solubilization, 
biocompatibility, and biodegradability of micelles.18,19   
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In an intriguing experiment, Shin, et al. examined the solubilization of three 
hydrophobic cancer drugs (paclitaxel (PTX), 17-allylamino-17-demethoxygeldanamycin 
(17-AAG), and rapamycin (RAP)) in poly(ethylene glycol)-block-poly(D,L-lactic acid) 
(PEG-b-PLA) micelles.3,19  Paclitaxel stabilizes microtubule polymers,20 a major 
constituent of cell mitosis, thus inhibiting the mitotic process of cancer cells.  17-AAG, 
also known as Tanespimycin, is an Hsp90 inhibitor, preventing proper folding of proteins 
and destabilizing the proteins required for tumor growth.21  Rapamycin is an mTOR 
inhibitor, preventing cell growth and cell cycle progression through its ability to minimize 
growth factor stimuli.22  By combining these agents, Shin, et al. demonstrated the 
effectiveness of the drug cocktail, showing the agents together  reduce tumor growth more 
rapidly than an individual drug treatment.19  In their experiment, they specifically 
evaluated the release rate of these agents from the micelle both individually and in 
combination.  Each combination of drug loadings decreased agent solubility compared to 
their individual solubilities.  For example, simultaneous release of PTX, 17-AAG, and 
RAP was slower in combination than independently, as measured by the half-life, t1/2, of 
drug release.  
Remarkably, Shin, et al. also asserted that t1/2 values correlated well with the 
logarithm of the oil-water partition coefficient.  However, for nondegrading polymeric 
matrices, solute transport is typically assumed to be a diffusion-driven process, with 
transport typically defined via Fick’s laws of diffusion.17,23,24  The timescale for diffusion-
driven systems is given by the square of the radius divided by the diffusivity coefficient.25  
Here the diffusivity is 1.3×10-12 m2/s, calculated from the Stokes-Einstein equation given 
a micelle diameter of 40 nm and viscosity of 8.5×10-4 Pa.s at 300 K.26  For systems 
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explored by Shin, et al., this characteristic time is on the order of 1 microsecond—orders 
of magnitude smaller than experimentally measured t1/2 values that are on the order of 
tens of hours.  In this article, we resolve this inconsistency by developing a mechanistic 
model to explain the experimental results presented by Shin, et al.  From first principles, 
we derive a two-parameter model that clarifies the mechanisms governing the half-life 
and allows straightforward fitting to experimental data. 
5.3 Methods 
Figure 5.2 depicts a concentration profile for an agent (e.g., any of the three defined 
by Shin, et al.) within the micelle in four regions: the core, the hydrophobic shell (e.g., 
PLA), the hydrophilic shell (e.g., PEG), and an external aqueous media.  Within each 
region, the concentration is constant (justified below) albeit time dependent.  Partition 
coefficients (e.g., local thermodynamic equilibrium coefficient), also known as K-
values,27 relate concentrations between regions. 
An integral balance around the exterior of the micelle gives the rate of agents leaving 
the micelle, 
݀݊௧௢௧ሺݐሻ
݀ݐ ൌ െ݇௖ܣ௦ሺܥଷሺݐሻ െ ܥஶሻ, (5.1) 
where ntot represents the moles of agent in all three internal layers, kc is the external mass 
transfer coefficient, As is the surface area of the micelle, C3(t) is the concentration at the 
surface of the micelle as a function of time t, and C∞ is the concentration far from the 
micelle.  The total moles of any individual agent within the spherical micelle may be 
determined by integration, 
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Each region of constant composition must be integrated separately 
݊௧௢௧ሺݐሻ ൌ 4ߨ ቂ׬ ݎଶܥ଴ሺݐሻ݀ݎ ൅௛଴ ׬ ݎଶܥଵሺݐሻ݀ݎ
ு
௛ ൅
׬ ܥଶሺݐሻ݀ݎோு ቃ, 
(5.3)
yielding 
݊௧௢௧ሺݐሻ ൌ 4ߨ3 ሾ݄
ଷܥ଴ሺݐሻ ൅ ሺܪଷ െ ݄ଷሻܥଵሺݐሻ
൅ ሺܴଷ െ ܪଷሻܥଶሺݐሻሿ. 
(5.4)
݊௧௢௧ሺݐሻ ൌ ௠ܸܭ ܥଷሺݐሻ. (5.5)









The overbar denotes scaling with respect to distance from the center of the micelle (e.g., 
ത݄ ൌ ݄ ܴ⁄ , ܪഥ ൌ ܪ/ܴ).  Taking the derivative of eq (5.5) and substituting into eq (5.1) 





ሺܥଷሺݐሻ െ ܥஶሻ. (5.7)
Eq (5.7) is an ordinary differential equation that may be solved analytically by 
separation of variables.  With the initial condition of C3(to)=C30, the solution to eq 5.7 
becomes 
ܥଷሺݐሻ ൌ ሺܥଷ െ ܥஶሻ݁
ቆି௞೎௄஺ೞ௏೘ ሺ௧ି௧బሻቇ ൅ ܥஶ. (5.8)
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This equation shows that the characteristic time for agent release is 
 ߬ ൌ ௠ܸ݇௖ܭܣ௦ ൌ
ܴ
3݇௖ܭ. (5.9)
Substituting eq (5.8) into eq (5.9) gives the total moles of drug in the micelle as a 
function of time, 
 ݊௧௢௧ሺݐሻ ൌ ௠ܸܭ ൥ሺܥଷ
଴ െ ܥஶሻ݁
ቆି௞೎௄஺ೞ௏೘ ሺ௧ି௧బሻቇ ൅ ܥஶ൩. (5.10)
The interfacial concentration is related to the concentration of the core via 
 ܥଷ଴ ൌ ݇ூூூ݇ூூ݇ூܥ଴଴. (5.11)
The total percent released, P, from the micelle as a function of time is defined as 
 ܲሺݐሻ ≡ 1 െ ݊
௧௢௧ሺݐሻ
݊௧௢௧ሺݐ଴ሻ. (5.12)
Substituting eqs (5.10) and 5.11 into eq (5.12) yields 




which gives the percent drug release from the micelle as a function of the mass transfer 
coefficient, the ratio of central and infinite drug concentrations, and the lumped 
thermodynamic factor (i.e., kc, C∞/Coo, and K, respectively).  This equation is used to 
analyze the experimental data reported by Shin, et al. 
 Additional physical insight may be obtained from eq (5.13).  The steady state 
concentration is 
 ܲሺݐ → ∞ሻ ൌ ቆ1 െ ܥஶ݇ூூூ݇ூூ݇ூܥଷ଴ቇ. (5.14)
Likewise, the half-life is calculated by determining when half this concentration is 
reached via eq (5.13) as 
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 ݐଵ ଶ⁄ ൌ lnሺ2ሻ ߬ ൌ lnሺ2ሻ ܴ3݇௖ܭ. (5.15)
This expression shows that the half-life depends on the partition coefficients through 
K as was anticipated by Shin, et al., even though simple diffusion does not govern. 
With time as the only independent variable and the percent release as the dependent 
variable, only two parameters remain available to match each data set: a concentration 
ratio C∞/(kIII kII kI C30), and the characteristic time, defined in eq (5.9), herein termed the 
lumped parameter.  To estimate each of these parameters, a nonlinear regression 
algorithm from the Statistics Toolbox® in the MATLAB® software tool was used.  The 
regression algorithm uses an iterative least squares method to estimate the parameters as 
reported in Table 5.1 for each data set presented by Shin, et al. 
This model will be compared to well-known solutions based on Fick’s second 
law.  In its most complete formulation, the driving force, di, for mass transfer of each 
species, i, is its chemical potential, i.  Taylor and Krishna26 show that the gradient in 
chemical potential is proportional to the gradient in species mole fraction, xi, 




where ܴ௚	is the gas constant, ܶ is the absolute temperature, ܲ is the pressure, ݊ is the 
number of species present, and ߁௜௝ is the thermodynamic factor.26  For ideal solutions, the 
thermodynamic factor becomes unity.  For a pseudo-binary system, the diffusive flux 
vector becomes 
 ࡶ௜ ൌ െ߁௜ܦ௜׏ܥ௜, (5.17)
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where Di and Γi represent the binary diffusion coefficient and thermodynamic factor.26  
Substitution into species conservation in the absence of convection and reaction (neither 
of which is likely significant for small micelles) gives  







in spherical coordinates.  From eq (5.18), the time scale for diffusion may be expressed 
in terms of the thermodynamic factor as 
 ߬௜ ൌ ܴ
ଶ
߁௜ܦ௜ . (5.19)
This expression resolves to the usual length squared over diffusivity ratio mentioned 
previously when thermodynamic nonideality remains negligible (i.e., ߁௜ ൌ 1). 
Smith, et al.27 show that the partition coefficient is related to the activity 
coefficient by taking the ratio of activity coefficients in each phase,  







where γi(1) and γi(2) are the activity coefficients of chemical species i in phase one and 
phase two, respectively.  Likewise, the thermodynamic factor is related to the partition 
coefficient through, 
 Γ௜ ൌ 1 ൅ ݔ௜ ߲ߛ௜߲ݔ௜. (5.21)
Thus, the partition coefficients at each interface shown in Figure 5.2 and the 
thermodynamic factor in eqs (5.20) and (5.19), respectively, may be estimated from an 
activity coefficient calculation. 
Typically, experimental phase equilibria data are not available to adequately define 
the activity coefficient.  Semi-empirical methods are usually used to estimate the activity 
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coefficient.  One of the best methods to estimate for liquid-liquid systems is the UNIFAC 
method.26,28-30  The UNIFAC method represents each pharmaceutical agent in terms of 
“structural units” or “subgroups.”26-31  The UNIFAC method is a frequently used method 
when no thermodynamic data are available, typical of drug delivery formulations.  
For the purposes of this study, each agent was divided into subgroups as given in 
the 2011 UNIFAC group contribution by Wittig, et al.31 This generated a list of functional 
groups (see Table 5.1).   
To determine the value of the lumped parameter, K from eq (5.6), the relative 
thicknesses of each layer in Figure 5.2 must be estimated.  Although the micelle diameter 
was reported as 36.9-43.8 nm in Table 1 of Shin, et al., h/R and H/R remain unknown but 
may be approximated using Kuhn’s freely jointed chain model.  The stretched out chain 
length is l=Nmlm=Nklk, where Nm is the number of mers determined in Table 5.3, lm is the 
length of a mer (0.148 nm for PEG32 and 0.295 nm for PLA33), Nk is the number of Kuhn 
lengths, and lk is the Kuhn length.  The Kuhn length is 0.60 nm for PEG32 and 6.07lm-
12.0lm=1.79-3.54 nm for PLA.33,34   The root-mean-square end-to-end distance is then 
given as N1/2lk, which with Table 5.3 is 2.90 nm for PEG and 3.41-4.79 nm for PLA.  The 
relative thicknesses then becomes 
ܪ
ܴ ൌ






ܴ െ ݈௞௉ாீට ௞ܰ௉ாீ െ ݈௞௉௅஺ඥ ௞ܰ௉௅஺
ܴ . 
(5.23)
Substitution gives ݄ ܴ⁄ ൌ 0.583 െ 0.712 and ܪ ܴ⁄ ൌ 0.843 െ 0.867. 
105 
 
Using eq (5.9) to describe mass transfer from an approximately 40 nm diameter 
stationary sphere in 300 K water gives a mass transfer coefficient of 6.36×10-5 m/s, the 
value used in this analysis.  
 
5.4 Results and Analysis 
This article presents a simple model to describe the release of pharmaceutical 
agents from micelles – individually and in combination.  This model, derived above, uses 
the lumped capacitance method instead of Fick’s second law to describe drug 
concentration profiles (see Figure 5.2).  The remainder of this article compares the model 
to experimental data, describes model parameters, evaluates the assumptions on which 
the model rests, and discusses when the model applies. 
Figures 5.3 through 5.5 quantitatively compare the model to experimental data 
from Shin, et al. The model (see eq (5.13)) fits the data well for each pharmaceutical agent 
individually and in combination.  Each curve in Figures 5.3 through 5.5, calculated using 
eq (5.13), generally falls within the error bounds of each measurement.  Occasionally 
(e.g., Figure 5.4c and Figure 5.5d), the curves falls slightly outside the experimental error 
bound.  The quality of the fit remains independent of the number and combination of 
pharmaceutical agent within the center of the micelle.  Combined, these data suggest that 
the proposed model accurately describes the delivery of a drug cocktail from a micelle. 
The model has only two parameters - as given in eq (5.13).   The first parameter 
is a concentration ratio that vanishes when the solution far from the micelle does not 
contain the agent.  Table 5.3 shows that this parameter is often nonzero, indicating some 
of the agent has “leaked” into the surrounding solution prior to the start of experimental 
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measurement.  Although the value is small, the model accounts for this discrepancy and 
is not biased when fitting the data.   
The second parameter is the lumped time scale given in eq (5.9).  This parameter 
depends on the micelle radius, the external mass transfer coefficient, and the lumped 
partition coefficient.  The micelle radius remains readily tunable through the polymer 
composition and the relative size of hydrophilic and hydrophobic blocks. This has been 
reviewed by Poon and Andelman.35  Larger micelles increase the time scale and decrease 
the rate of agent release.  The external mass transfer coefficient may be calculated from 
first principles as summarized by Deen25 or estimated using a heat and mass transfer 
analogy as summarized by Incropera, et al.36  For a micelle in quiescent solution, the 
Sherwood number is two.  Recognizing this, the mass transfer coefficient may be 
determined directly (kc=ShΓiDi/(2R)).  Where there is significant external flow relative to 
the micelle, Incropera, et al. 36 provide correlations for the Sherwood number as a function 
of the flow velocity.  As the external velocity increases, the timescale for release shrinks 
and the rate of release goes up.  This may be important in the circulatory system, for 
example, where the velocity of a micelle in the blood stream would vary considerably. 
Considering the circulatory system, these correlations combined with eq (5.13) provide 
an opportunity (outside the scope of this article) to estimate the rate of agent release in 
each portion of the blood stream from first principles.  The final factor is the lumped 
partition coefficient.  This factor may be determined directly from experimental data or 
estimated from thermodynamic correlations.  Table 5.3 shows the characteristic time from 
eq (5.13) fitted from the experimental data from Shin, et al. 
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Alternatively, the lumped parameter may be estimated directly from the UNIFAC 
model.  As explained above, the activity coefficients may be estimated by selecting 
UNIFAC subgroup parameters in the 2011 UNIFAC parameter update30 as shown in 
Table 5.2.31  Table 5.3 shows that the characteristic time may be predicted within a factor 
of 2 to 4 for highly hydrophobic agents, like PTX and RAP using the UNIFAC method 
to predict the lumped partition coefficient.  There is significantly poorer agreement for 
the less hydrophobic drug, 17-AAG.  This agreement remains far better than estimates 
from simple diffusion, which overpredict mass transfer by more than six orders of 
magnitude.  This indicates that the UNIFAC method most likely overpredicts the partition 
coefficients. 
The half-life for each data set can be determined by using the empirical model fits 
and inserting estimated parameters into eq (5.13).  The calculated half-lives are also 
shown in Table 5.3 and compared to the half-lives given by Shin, et al.  Comparison 
between the model and the experiment demonstrates less than a 16% difference in all but 
one case.  This is also evidenced qualitatively from the plots in Figure 5.3 through Figure 
5.5.  The most significant aspect of the model is that it does not use any transport 
properties that describe diffusion within the micelle, thus signifying that mass transfer 
within the micelle is not diffusion controlled.  Indeed, none of the fitted parameters 
involve factors associated directly with diffusion within the micelle, although mass 
transfer outside of the micelle remains an essential factor in agent release.  This result 
contrasts with the assertion given by Shin, et al., that delivery is purely diffusion driven.  
Additionally, the characteristic times show similar characteristics to the LogP calculation 
presented by Shin, et al.  The LogP factor is a measure of the relative affinity of a 
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compound in nonionized water versus an immiscible model lipid solvent, which in this 
application is the pharmaceutical agent, at equilibrium. The value of LogP can be utilized 
as a gauge of the relative toxicity of a drug within the body.37  Thus, LogP values can be 
calculated to give a relative measure of the hydrophobicity of a molecule and by extension 
the relative toxicity of a pharmaceutical agent. 
The model presented here makes effective use of the “lumped capacitance 
method,” commonly used in heat transfer analyses36 to provide an original and highly 
accurate solution to the problem of estimating drug release rate from 
hydrophobic/hydrophilic micelles.  Formally, this transient mass transfer method applies 
only when convective mass transfer away from the micelle is significantly slower than 
diffusive mass transfer within the micelle.  Such gradients would only persist outside the 
micelle.36  Traditionally, this requirement has been expressed via the mass transfer Biot 
number, Bim,  
Bi௠ ൌ ݇௖ܴ߁௜ܦ௜, (5.24)
given here with the binary thermodynamic factor.  A small Bim indicates that mass 
transfer is much greater within the micelle than outside of the micelle, and the lumped 
capacitance method is only valid when Bim<0.1.36  In contrast, the Bim for this system is 
approximated by using the mass transfer coefficient for a spherical micelle in quiescent 
media, using the Stokes-Einstein diffusivity approximation, and the thermodynamic 
coefficient from experimental data, yielding a Bim much larger than the valid range of 
less than 0.1.  Thus, using common approximations for the system under assessment the 
lumped capacitance method should not be valid since Bim>>0.1. 
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However, the thermodynamics of phase separation resolve this apparent 
discrepancy. Using the UNIFAC method, the activity coefficients for each of the 
pharmaceutical agents in water may be calculated as a function of the mole fraction, 
shown in Figure 5.6.  From Figure 5.6, ln(γi) of each component is initially positive and 
rapidly decreases as mole fraction increases.  A negative value for ln(γi) denotes a region 
where there are negative deviations from ideal behavior (where adhesive forces exceed 
cohesive forces).27  The rate of mass transfer would thus be attenuated in this region of 
non-ideality and any agent with negative deviation would resist transport into an aqueous 
phase.   
In addition to this region of a negative deviation, spinodal decomposition occurs 
at low concentrations before the local minima of ln(γi) is reached (see Figure 5.6).  
Unstable phase separation occurs within this region of spinodal decomposition and 
suggests the possibility of hydrophobic molecule clustering on the outer edge of the 
micelle to form in essence a separate phase prior to separating from the micelle.  As the 
derivative of ln(γi) goes to zero (i.e., the minima) the spinodal limit is approached, as 
shown by the solid black line in Figure 5.6.  Therefore, mass transfer within the micelle 
is rapid, until the hydrophobic drug molecules reach the micelle surface where molecular 
forces effectively delay release into the water phase, satisfying the intent of the lumped 
capacitance method, even where the Bim restriction does not formally govern. 
Given the success of using internal diffusion to describe release rates of other 
systems, the question arises of when this lumped capacitance model should be employed 
as opposed to an internal diffusion model.  The ratio of the characteristic time scale for 
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internal diffusion (eq (5.19)) to the characteristic time scale for the proposed model 





when diffusional forces within the micelle are much faster than other mass transfer 
processes, or when micelles are particularly small, the lumped capacitance method 
presented herein is valid for estimation of drug delivery rates.  If diffusion is slow or the 
micelle is large, significant concentration gradients would exist violating the constant 
composition approximation required for our model. 
5.5 Conclusions 
A lumped capacitance model similar to that often used in heat transfer calculations 
has been applied to the problem of estimating the rate of drug delivery from 
hydrophobic/hydrophilic micelles.  The proposed lumped capacitance model for drug 
delivery shows excellent agreement with the experimental data of Shin, et al.19  The 
results demonstrate clearly that external mass transfer and not diffusion governs release 
from small micelles. 
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Figure 5.1 – Conceptual model of a PEG-b-PLA micelle containing a three-drug micelle 
prior to release. 
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Figure 5.2 – A conceptual one-dimensional representation of the expected concentration 
profile of a pharmaceutical agent within a micelle.  The highest concentration of the 
pharmaceutical agent is located in the core of the micelle, shown as Co.  The concentration 
decreases step-wise as distance from the center of the micelle increases.  Concentrations 
within the hydrophobic PLA shell from h to H and the hydrophilic PEG shell from H to 
the micelle radius, R, are C1 and C2, respectively.  The micelle surface concentration, 
located immediately outside the micelle, is represented as C3, with a concentration of C∞ 
far from the micelle surface. The partition coefficient at each interface of the micelle 
arises from the concentration ratio of adjacent phases (shown as kI, kII, and kIII). 
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Figure 5.3 – The fitted curves using eq (14) for 17-AAG loaded (a) individually, (b) with 
PTX, (c) with RAP, and (d) with PTX and RAP against experimental data provided by 
Shin, et al. 
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Figure 5.4 – The fitted curves using eq (14) for PTX loaded (a) with RAP, (b) with 17-
AAG, and (c) with RAP and 17-AAG against experimental data provided by Shin, et al. 
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Figure 5.5 – The fitted curves using eq (14) RAP loaded (a) individually, (b) with PTX, 
(c) with 17-AAG, and (d) with PTX and 17-AAG against experimental data provided by
Shin, et al. 
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Figure 5.6 – The calculated natural logarithm of the activity coefficient (ln(γi)) of each 
pharmaceutical agent (i.e, 17-AAG (green solid line), PTX (blue dashed line), and 
RAP(red dotted line)) in water  through the UNIFAC method as a function of the mole 
fraction.  The spinodal limit is shown (solid black line) demarking where spinodal 













Table 5.1 – Model-fitted parameters using the experimental data reported by Shin, et al. 
for in vitro release of pharmaceutical agents from using eq (5.13). 
Agents Concentration Ratio C∞/(kIII kII kI Coo) 
Characteristic 
time (hr)b Half-life (hr)c 
PTX NAa NAa NAa 
17-AAG 0.056 2.172 1.505 
RAP 0.109 12.28 8.511 
PTX 0.208 7.230 5.011 
17-AAG 0.060 2.512 1.741 
RAP 0.071 12.61 8.743 
17-AAG 0.060 2.601 1.803 
RAP 0.036 16.26 11.27 
PTX 0.072 10.08 6.984 
RAP 2.10.10-9 18.23 12.63 
PTX 5.78.10-4 12.17 16.07 
17-AAG 0.059 3.508 2.432 
aNot applicable due to excessive drug precipitation and no data available for fitting. 
bDefined in eq (5.9). 
cDefined in eq (5.15). 
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Number Subgroup PTX 17-AAG RAP PEG PLA Water
1 1 CH3 6 1 6 0 0 0
1 2 CH2 2 2 12 95 0 0 
1 3 CH 3 10 15 0 1 0 
1 4 C 3 1 2 0 0 0 
15 3 ACH 16 3 0 0 0 0 
19 4 ACCH2 0 1 0 0 0 0 
34 5 OH 3 1 3 1 1 0 
36 7 H2O 0 0 0 0 0 1 
42 9 CH3CO 2 2 1 0 23 0 
33 9 CH2CO 4 2 4 0 0 0 
59 13 CH3O 0 2 3 0 0 0 
60 13 CH2O 0 0 0 95 0 0 
61 13 CHO 5 1 2 0 22 0 
72 15 CH2NH 1 1 1 0 0 0 
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Table 5.3 – Experimental values reported by Shin, et al. for in vitro release of agents 

















PTX NAa NAa NAa 3.0 NAa NAa 
17-AAG 0.056 1.32 1.505 1.3 1.55 2.16.10-2
RAP 0.109 8.52 8.511 5.8 8.77 3.48 
PTX 0.208 5.01 5.011 3.0 5.16 2.65 
17-AAG 0.060 1.74 1.741 1.3 1.79 2.32.10-2
RAP 0.071 8.73 8.743 5.8 9.01 3.42 
17-AAG 0.060 1.80 1.803 1.3 1.86 2.17.10-2
RAP 0.036 10.05 11.27 5.8 11.6 3.19 
PTX 0.072 6.00 6.984 3.0 7.20 2.73 
RAP 2.10.10-9 13.93 12.63 5.8 13.0 3.17 
PTX 5.78.10-4 9.20 16.07 3.0 8.70 2.72 
17-AAG 0.059 2.52 2.432 1.3 2.51 2.28.10-2
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CHAPTER 6 
CONCLUSIONS AND FUTURE WORK 
The general purpose of the study was to use engineering techniques to answer 
fundamental questions concerning EoE development and treatment.  These methods and 
techniques are common in traditional engineering applications (e.g., fluid dynamics, heat 
transfer, etc.) and are used to obtain insight into a physical system through mathematical 
application.  By applying these engineering methods, insight is developed into the 
physical parameters and conditions contributing to a diseased state.   
First, an examination of the relationship between concentration and the curvature of 
the esophagus was performed.  The transport of casein was modeled using an idealized 
esophageal geometry; casein concentration profile in the epithelium was observed to be 
significantly impacted by curvature of the esophagus.  This result agrees with 
experimental observations and if esophageal curvature can be reduced, plaque and 
regions of elevated eosinophil concentrations may be minimized. 
A species conservation model was developed to represent a simplified pathogenesis 
model of EoE.  These equations were examined using linear stability analysis, which 
concluded transport described by these equations is unconditionally stable.  Thus, a 
parametric assessment of the conservation equations was performed. The parametric 
assessment determined the reactive interactions between biomarker components (e.g., 
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eotaxin-3) and eosinophils are highly significant.  To better understand and control EoE, 
continued work should investigate the rates in which these components react with each 
other.  If the reactions can be slowed or even disabled, EoE could be conceivably 
eliminated.   
In addition, a model was developed to describe the delivery of polymer micelles 
loaded with hydrophobic drugs.  This model can be used to predict drug delivery time 
scales for a wide range of pharmaceutics, which can be used to treat EoE.  Using the 
model, drug release can be tailored such that the micelles can be applied directly to the 
esophagus for a timed release to the affected areas, leading to more efficient and effective 
treatment of EoE. 
The use of numerical and analytical analyses is an important foundation to study the 
development of EoE.   This foundation was used here, and to build upon this effort, a 
more detailed model of the esophagus may be developed.  Ideally, this model would 
account for fluid-epithelial interaction and absorption of antigen into the esophagus.  By 
accounting for the highly variable geometry of the esophagus, and the flow of mucin 
down the esophagus, a more detailed map of eosinophil density may be possible.  That 
type of information could be directly related to patient measurements, leading to an 
absorption-diffusion-reaction model of EoE. The implications of this approach can give 
an individual a model that can be used to best treat EoE for a wide range of patient 
scenarios and conditions, which can be examined to determine the precise cause of a 
patient’s individual response to an EoE response. 
To identify long-term trends of the disease and under what conditions one could be 
diagnosed with EoE, additional effort should be undertaken to carefully examine the 
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equations that define the pathogenesis.  The model presented in this work was simplified 
to yield general trends.  This resulted in unconditionally stable conditions, but it reveals 
important factors governing EoE development, in particular, the interactions and rates of 
reaction between activation components and eosinophils that govern the mass transfer 
within the epithelium.  Naturally, different approaches and models may result in a system 
of equations that will clarify the applicable physical parameters that could lead to a 
diseased state.   Collecting EoE data will be important for validating computational any 
models and appreciating transport phenomenon within the esophagus.  Currently, the data 
available are not well suited from modeling to identify a coherent pathogenic model of 
EoE. 
It is believed that through the development of biophysics-based models and the 
application to biological systems, better predictions of diseases, like EoE, can be 
determined and methods of treatment can be more readily defined.   This effort is opening 
a new avenue in the assessment and treatment of the EoE disease state and points to 
methods for better understanding of disease pathogenesis.  
